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 Introduction. The effects of transplacental viral infections on the 
developing fetus are dependent upon complex interactions between feto-
placental and maternal immune responses and the stage of fetal development at 
which the infection occurs. Bovine viral diarrhea virus (BVDV) has the ability to 
cross the placenta and infect the fetus. Infection early in gestation with non-
cytopathic (ncp) BVDV leads to persistent infection (PI) due to the development 
of virus-specific immunotolerance, which results in life-long viremia and 
detrimental developmental consequences for many organ systems.   PI with 
BVDV has been associated with osteopetrosis, other long bone lesions, and 
fractures in fetuses and calves. This study was undertaken to characterize the 
morphogenesis of fetal long bone lesions; determine the effects of PI on 
biomechanical properties of fetal femora; and delineate the temporal 
development of the fetal and placental innate immune responses during the 
establishment of PI. 
 Materials and Methods. Forty-six BVDV-naïve pregnant Hereford heifers, 
approximately 18 months old, were inoculated either with non-cytopathic BVDV 
type 2 containing media or media alone on day 75 of gestation to produce PI and 
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control fetuses, respectively, which were collected via Cesarean section on the 
following days of gestation: 82 (peak of maternal viremia), 89 (beginning of 
maternal seroconversion, acute stage of fetal infection), 97 (Maternal 
seroconversion and aviremia, fetal viremia), 192 (chronic stage of fetal persistent 
infection), and 245 (chronic stage of fetal persistent infection, near term). 
 Results. Experiment I: The morphogenesis of fetal skeletal lesions.  
Radiographic and histomorphometric abnormalities were first detected on day 
192, at which age PI fetal long bone metaphyses contained focal densities (4/7 
fetuses) and multiple, alternating (cyclic) transverse radiodense bands (3/7 
fetuses). Day 245 fetuses were similarly affected. Histomorphometric analysis of 
proximal tibial metaphyses from day 192 fetuses revealed transverse zones with 
increased calcified cartilage core (Cg.V/BV, %) and trabecular bone (BV/TV, %) 
volumes in regions corresponding to radiodense bands (P<0.05). Numbers of 
tartrate resistant acid phosphatase positive osteoclasts (N.Oc/BS, #/mm2) and 
bone perimeter occupied by osteoclasts (Oc.S/BS, %) were both decreased 
(P<0.05). Mineralizing surface (MS/BS, %), a measure of tissue level bone 
formation activity, was reduced in PI fetuses (P<0.05). 
 Experiment II: The effect of PI on the biomechanical properties and 
composition of fetal femora. PI fetuses had femora with smaller mid-
diaphyseal diameters and lower cortical porosity than controls. There were no 
differences between PI and Control fetuses in cortical thickness ratio, ash density 
nor calcium or phosphorous content; however, cortical thickness ratio decreased 
with fetal age. Although differences in elastic modulus (PI vs Control and day 192 
iv 
vs day 245) and ultimate stress (day 192 vs day 245) were identified, cortical 
thickness ratio largely accounted for these observed differences. 
 Experiment III: Fetal and Placental innate immune response to PI.  
Fetal viremia was confirmed starting on day 89. Significant up-regulation of 
mRNA encoding cytosolic dsRNA sensors - RIG-I and MDA5 - was detected on 
days 82 -192. Detection of viral dsRNA by cytosolic sensors leads to the 
stimulation of ISGs, which was reflected in significant up-regulation of ISG15 
mRNA in fetal blood on days 89, 97, and 192. No difference in IFN- and IFN- 
mRNA concentration was found in fetal blood or caruncular tissue, while a 
significant increase in both IFN- and IFN- mRNA was seen in cotyledons from 
PI fetuses on day192. 
 Conclusions. It is concluded that PI with BVDV induces cyclic abnormal 
trabecular modeling, which is secondary to reduced numbers of osteoclasts. The 
factors responsible for these temporal changes are unknown but may be related 
to the time required for osteoclast differentiation from precursor cells. However, 
fetal infection with BVDV did not significantly impair inherent biomechanical 
properties of fetal bone but rather resulted in decreased periosteal apposition 
rates, which manifest as altered cortical geometry.  Differences in cortical 
geometry disproportionally affect the error associated with calculation of stress 
and strain by classical beam theory equations and, therefore, critical 
assumptions necessary for use of these equations are not satisfactorily met 
when comparing samples differing solely in mid-diaphyseal diameter. 
Furthermore, fetuses respond to early gestational ncp BVDV infection by 
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induction of the type I IFN pathway, resulting in chronic up-regulation of ISGs. 
Cotyledonary tissue contributes to up-regulation of ISGs by increased production 
of IFNs. The innate immune response might partially curtail viral replication in PI 
fetuses, but is unable to eliminate the virus in the absence of a virus-specific 
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 BVDV, a small (12.5 kb genome) positive sense RNA virus, is a member 
of the genus Pestivirus in the Family Flaviviridae.  Since its discovery in the late 
1940s, BVDV has become the most economically important viral disease of cattle 
with monetary losses to the U.S. cattle industry exceeding $400 million annually 
(Fray et al., 2000a; Gunn et al., 2004; Houe, 1999).   BVDV has arguably 
received more attention in terms of research effort than any single disease agent 
affecting cattle. A recent PubMed search, using the term ―bovine viral diarrhea‖ 
revealed more than 3,400 manuscripts devoted to understanding the impact, 
pathogenesis, epidemiology and control of BVDV. In nature, BVDV occurs as two 
biotypes: noncytopathic (ncp) and cytopathic (cp). Ncp strains are exceedingly 
more common, likely due to their ability to cause persistent infection (PI) in 
contrast to cytopathic strains, which lack this ability.  
 
Historical Perspectives 
 A novel disease of cattle, later proven to be caused by infection with 
BVDV, was first described in 1946 by two individual groups working 
independently (Childs, 1946; Olafson et al., 1946). The two reports appear to 
describe the same disease although the morbidity and mortality differed widely 
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between the reports. Olafson et al. (1946) reported that most animals within a 
given herd, irrespective of age were affected but only 3-4 % of those died 
(Olafson et al., 1946). In contrast Childs (1946) reported that only a few, primarily 
young animals were affected and most cases appeared to be fatal (Childs, 1946). 
While this discrepancy certainly could be due to differences in BVDV strain 
virulence it is also possible that most of the acute infections were asymptomatic, 
and thus went unnoticed by Childs (1946) or that herds evaluated by these two 
groups differed significantly in the number of PI animals leading to increased 
incidence of fatal mucosal disease in the cases described by Childs (1946) and 
thus explaining the reported differences in mortality and morbidity.  It is clear, in 
retrospect, that both of these reports contain descriptions of two similar but 
distinct manifestations of BVDV infection, both viral diarrhea and animals which 
presented with severe disease grossly characterized by mucosal erosions and 
ulcers causing the latter condition to be dubbed mucosal disease by Ramsey and 
Chivers in 1953 (Ramsey, 1953).   Although a viral etiology was strongly 
suspected (Olafson et al., 1946) initial isolates of BVDV were noncytopathic 
strains and thus undetectable in cell culture. Cytopathic variants were later 
isolated in 1957 (Underdahl, 1957).  Viruses obtained from animals with viral 
diarrhea and those obtained from cases of mucosal disease were shown to be 
similar serologically, and produced diarrhea in experimentally infected animals, 
however neither virus was able to reproduce fatal mucosal disease (Gillespie, 
1961).  
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 The presence of abortions in many BVDV outbreaks in both the USA and 
Great Britain lead to the suspicion that BVDV was capable of transplacental 
infection resulting in abortion (Dow, 1960; Olafson et al., 1946). Although the 
relationship between BVDV and abortion was formally hypothesized in 1968 
(Kahrs, 1968) it was not confirmed until fetal infection was reproduced 
experimentally (Caraso, 1971; Kahrs, 1973).  Investigation of transplacental 
infection and the effects of such infection on the developing fetus would lead to 
considerable progress in understanding the pathogenesis of mucosal disease 
and BVDV epidemiology.   
 From experimental fetal infections it became clear that the result of 
transplacental infection was determined by the stage of gestation in which the 
infection occurred; infection early in gestation lead to abortion or stillbirth, 
infection late in gestation lead to precolostral seropositive fetuses which 
outwardly appeared normal, whereas when infection occurred prior to 120 days 
of gestation the virus persisted postnatally (Malmquist, 1968; Thompson, 1963). 
These initial studies lead to the discovery of PI; the mechanism which enabled 
fetuses to become PI (immunotolerance) was documented along with an 
important observation that only immunotolerant, PI fetuses developed mucosal 
disease (Leiss, 1974). Although significant progress in understanding the 
pathogenesis of BVDV and the effect on the developing fetus was made in the 
subsequent decade, the etiology of mucosal disease remained elusive until it 
was reproduced experimentally by Brownlie et al in 1984 (Brownlie, 1984). 
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The Pathogenesis of Transplacental Infection  
 The pathogenesis of transplacental BVDV infection has been an area of 
consistent study since the original transplacental infection studies (Caraso, 1971; 
Kahrs, 1973) performed in the early 1970s.  The effects of transplacental 
infection, particularly PI, on developing fetuses include lesions in the 
musculoskeletal  (brachygnathia, growth arrest lines, growth retardation lattices, 
osteopetrosis; reviewed in CHAPTER II and CHAPTER III) (Constable et al., 
1993; Espinasse, 1986; Nuss et al., 2005; O' Connor, 1993; O'Toole, 2006; 
Scruggs, 1995; Webb et al., 2012), integumentary (hypotrichosis, alopecia, 
perivascular dermatitis) (Brown, 1975; Larsson, 1991), ocular (microphthalmia, 
cataracts, retinal degeneration, optic neuritis) (Brown, 1975), cardiopulmonary 
(pulmonary hypoplasia, myocarditis), and immune systems (thymic aplasia and 
atrophy, pulmonary lymphoid hyperplasia), although those within the central 
nervous system (cerebellar hypoplasia, hydrancephaly, hydrocephalus, 
hypomyelinogenesis, mircoencephaly) have been studied much more extensively 
(Bielefeldt-Ohmann, 1995; Brock, 2004; Montgomery, 2008; Ridpath, 2010).  
  Transplacental infection of the fetus occurs almost exclusively in 
seronegative cattle as maternal antibodies are effective in preventing 
establishment of virus in the fetoplacental unit (Brownlie et al., 1998). There is 
considerable variation in the manifestation of transplacental infection which 
appears to be caused by variations in biologic properties of the virus 
(pathogenicity), biotype, and stage of gestation at time of infection (Kelling, 2007) 
and only ncpBVDV are capable of causing PI (Brownlie et al., 1989; Coria and 
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McClurkin, 1978; Harding et al., 2002). There is controversy surrounding the 
mechanism and route by which BVDV reaches the fetus.  Historically, infection of 
the placenta was thought be a prerequisite for fetal infection (Caraso, 1971) and 
has been offered as an explanation for the apparent resistance of early term (<30 
Days) fetuses to infection because the placenta is not well formed at this stage 
(Whitmore, 1981).  However, work by Fredriksen et al. (1999) suggests that virus 
reaches the fetus via the hematogenous route and that infection of the placenta 
therefore occurs in a ‗retrograde‘ manner (Fredriksen, 1999).   
 During acute infection of susceptible cattle, maternal viremia is evident 
beginning at 2 days post infection (Kelling, 2007) and peaks at 7 days post 
infection (Smirnova et al., 2008). Viral RNA and antigen does not appear in the 
fetus until around 14 days post maternal infection (Fredriksen, 1999); Chapter IV, 
Figure 14) which precedes antigen in the placenta by 2-8 days.   Given the 
ruminant epitheliochorial placental structure (Leiser and Kaufmann, 1994; Leiser 
et al., 1997), direct hematogenous spread of virus to the fetus during maternal 
viremia would require either the virus itself or resultant maternal immune 
response to induce placental damage sufficient to cause mixing of maternal and 
fetal blood or alternatively, employ a specialized viral strategy that would mediate 
efficient viral transport across the placenta. To date there is no indication that the 
latter occurs.  Purportedly, lesions in the placentomes following experimental 
infections of cattle are minor in nature or absent (Done et al., 1980; Kendrick, 
1971).  This contrasts sharply with the moderate to severe, often necrotizing 
placentitis caused by inoculation of pregnant ewes (Parsonson, 1979; Snowdon, 
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1975) and goats (Lamm et al., 2009) with bovine BVDV strains. The expedience 
with which BVDV reaches the ovine fetus (~72 hours) (Swasdipan et al., 2002) 
may suggest that in the case of cattle, placental damage, albeit not severe or 
potentially not even evident on the light microscopic level, is sufficient to enable 
hematogenous spread of BVDV to the bovine fetus. 
 The acute phase of PI with BVDV has received relatively less attention 
than the pathogenesis of acute BVDV infection in postnatal animals which closely 
mirror that of transient infections in late term fetuses. In the acute phase of PI, 
following hematogenous spread of virus to the fetus, there is evidence that 
vimentin positive (mesenchymal) cells, possibly endothelial cells, are the primary 
site of virus replication (Fredriksen, 1999). Not surprisingly these virus infected 
cells occur in organs that filter large quantities of blood, the liver and lung 
(Fredriksen, 1999). Initial viral infection of these cells is followed by virus 
dissemination in CD45 positive mononuclear cells, likely cells of the monocyte-
macrophage linage, to nearly all organs including the intestine, brain, spleen and 
thymus (Bielefeldt-Ohmann et al., 2012; Bielefeldt-Ohmann et al., 2008; 
Fredriksen, 1999).  The mechanism of transplacental spread of virus to the fetus 
of PI dams appears to differ slightly (Fredriksen et al., 1999).  
 Fetal viremia peaks sometime between 22 days and 119 days post 
maternal infection and then appears to decrease considerably later in the stage 
of PI (~120 days post maternal infection) and stabilize until term (CHAPTER IV, 
Figure 14). The exact reason for the decline in the level of viremia is unclear but 
may be related to a partially effective innate immune response (CHAPTER IV). 
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Subtle microscopic lesions within the vasculature occur in the brain of infected 
fetuses as early as 14 days post maternal infection (Bielefeldt-Ohmann et al., 
2012) and within the long bone metaphysis (21 days post maternal infection) 
(Webb et al., 2012), but florid histologic and gross lesions do not appear until 
much later in the stage of infection (~120 day post infection) when lesions of the 
central nervous system (microcavitation, etc) and skeletal system (described in 
Chapter II) are predominate findings (Bielefeldt-Ohmann, 1995; Bielefeldt-
Ohmann et al., 2012; Bielefeldt-Ohmann et al., 2008; Montgomery, 2008; Webb 
et al., 2012).  Although a plethora of lesions have been associated with 
transplacental infection with BVDV many are difficult to reproduce experimentally 
(cerebellar hypoplasia) (Bielefeldt-Ohmann, 1995).  
 There appears to be not only considerable differences in the 
manifestations of infection between ncpBVDV strains but also considerable 
differences within controlled experimental infections using the same virus strain. 
Most importantly, there is little understanding of the molecular mechanisms 
responsible for a majority of these lesions given that the infecting viral strain is 
noncytopathic in nature and reportedly is quite successful in preventing apoptosis 
in infected cells (Schweizer and Peterhans, 2001; Zhang et al., 1996).  Certainly 
one possibility is that the mechanism of injury is immunologically mediated and 
with the lack of a measurable adaptive immune response may suggest that the 
innate immune response to PI may be responsible (reviewed in CHAPTER IV).  
A single mechanism is also unlikely to be responsible as reduced cellular 
function in virus infected cells likely contributes as well (Kaariainen, 1984). 
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 The fetal immune response to PI and the exact mechanisms surrounding 
the development of immunotolerance have been subjects of debate and research 
efforts concentrated on these subjects have given rise to additional questions 
that further underscore the lack of current understanding.  Since the first 
description of immunotolerance to BVDV, following maternal infection prior to 
(~120 days) (Leiss, 1974), numerous studies have added to our understanding of 
the underlying mechanisms (Collen and Morrison, 2000; Coria and McClurkin, 
1978).  It has been shown that PI animals have complete T cell tolerance to the 
infecting virus strain which is highly specific in nature such that the animal can 
respond to the virus when a mutation results in a change of only one amino acid 
(Collen and Morrison, 2000).   
 Complete T cells tolerance should ablate any T cell dependent antibody 
production, however the question remains whether or not an attenuated B cell 
response leads to antibody production in PI animals.  BVDV specific antibodies 
are however present in a subset of PI cattle which strongly suggests that BVDV-
specific antibody production occurs (Collins, 1999). One study documented co-
localization of BVDV antigen and immunoglobulin, consistent with immune 
complexes, deposited within the germinal centers of PI lymph nodes, suggesting 
that antibody is produced (Fray et al., 2000b). Other explanations for antibody 
production would entail placentitis resulting in crossover of maternal antibody or 
generation of virus quasispecies.  The latter explanation is more attractive given 
the reported absence of placental lesions following transplacental infection and 
the presence of antibody in older PI animals (Collins, 1999; Done et al., 1980; 
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Fredriksen, 1999; Kendrick, 1971).  Apparently BVDV suffers from genomic 
instability arising from a multitude of different mechanisms which result in 
recombination (Meyers et al., 1992),  point mutations (Hamers et al., 2001), 
deletions, duplications and recombination with host mRNA (Meyers and Thiel, 
1996).  Production of viral quaisispecies may be the end result of these events 
and it has been proposed that quasispecies differing antigenicly from the original 
infecting strain are the impetus for antibody production in PI animals (Collins, 
1999).  
 Although our understanding of the immunology of PI has dramatically 
increased over the past few decades adequate explanations for the ability of 
ncpBVDV to cause PI have proven elusive.   Certainly immunotolerance to the 
infecting strain is central to this mechanism, but additional pestivirus specific 
characteristics must be involved to explain why other viruses, such as Blue 
tongue virus, Akabane, Wesselsbron virus (also a Flavivirus), Bovine herpesvirus 
1, and Bovine parvovirus, which are capable of causing transplacental infection 
in early gestation do not result in PI to those viruses.  Inhibition of type I 
interferon production by ncpBVDV has been implicated as one of the major 
mechanisms responsible (Peterhans et al., 2003; Schweizer et al., 2006) but 
there is evidence that refutes this hypothesis (Shoemaker et al., 2009; Smirnova 





Postnatal effects of transplacental infection  
 The postnatal effects of transplacental infections have received relatively 
little attention and a majority of the work has focused on PI animals (Houe, 1993; 
Loneragan et al., 2005). The results of these studies compellingly show a 
predisposition to comorbid disease and increased mortality in PI cattle (Houe, 
1993; Loneragan et al., 2005).  Numerous factors have been suggested to 
explain this including reduced microbial killing ability and chemotaxis (Welsh et 
al., 1995), inhibition of interferon production (Schweizer and Peterhans, 2001), 
and overall reduced cellular function (Kaariainen, 1984). Interestingly, fetuses 
infected after approximately 120 days of gestation and born seropositive to 
BVDV, had a two-fold increase in risk of serious calfhood diseases (Muñoz-Zanzi 
et al., 2003). Many if not all of the mechanisms/factors hypothesized to be 
responsible for ‗immune deficits‘ in PI animals hinge on the presence of BVDV 
itself and therefore are clearly inappropriate to explain the similar postnatal 
effects observed in fetuses transiently infected with BVDV, which clear the virus 
in utero.  Muñoz-Zanzi et al. (2003) clearly show that the potential impact, on an 
individual animal basis, of transient transplacental infections (incidence 9.6%) far 
surpass the impact of PI (0.5%).  Thus, from a production standpoint, even by 
eliminating PI animals, approximately 10% of the herd could still have a 
predisposition to disease.  The potential economic impacts on the cattle industry 
are immense. While the mechanisms responsible for the postnatal health effects 
of transplacental BVDV infection are not known, the condition bares striking 
resemblance to developmental immunotoxicities associated with in utero 
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exposure to various compounds including dexamethasone (Dietert et al., 2003), 
lead (Bunn et al., 2001) and others.  The postnatal effects of transplacental 
infection with BVDV are consistent with the fetal origins of adult disease 
hypotheses first put forth by Barker (Barker, 1994).  Work in the last decade 
strongly suggests that epigenetic dysregulation is the mechanism underlying the 
postnatal effects of in utero fetal insults.  There is a small body of evidence to 
suggest that fetal epigenetic dysregulation occurs in transplacental BVDV 
infections (APPENDIX IV), and it is plausible that it is responsible for the 
postnatal health effects.   
 The underlying purpose of the subsequent experiments was to investigate 
the acute, subacute and chronic stages of PI with BVDV in an attempt to 
understand: 1) how this disease results in skeletal lesions, 2) whether such 
lesions lead to impaired structural integrity of long bones, and 3) the nature of the 













BOVINE VIRAL DIARRHEA VIRUS CYCLICALLY IMPAIRS LONG BONE 




 BVDV (genus Pestivirus, Family Flaviviridae) is taxonomically divided into 
BVDV1 and BVDV2 genotypes, both of which contain cytopathic (cp) and 
noncytopathic (ncp) biotypes (Gillespie, 1960; Hamers et al., 2001; Ridpath et al., 
1994). The majority of BVDV infections, regardless of infecting strain type, result 
in asymptomatic infections that largely go undetected. While acute infections can 
occur with either biotype, infection with a ncp strain of BVDV, regardless of 
genotype, appears to be a prerequisite for persistent infection (PI) of the fetus 
(Brownlie et al., 1989; Coria and McClurkin, 1978; Harding et al., 2002). 
 NcpBVDV, by virtue of its ability to cross the placenta and infect the fetus 
at any stage of gestation, has been associated with a myriad of different 
manifestations including early embryonic death, abortion, fetal PI, and congenital 
abnormalities (Bielefeldt-Ohmann, 1995; Done et al., 1980; Duffell et al., 1984). 
The fetal consequences of transplacental infection appear to be primarily 
determined by the age of the fetus at the time of infection, although other factors 
such as the pathogenicity of the infecting virus strain and the immune and health 
status of the dam may contribute (Brock, 2003). Transplacental infection of the 
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fetus by ncpBVDV prior to adaptive immune system development, which occurs 
during the second and third trimester of gestation, is thought to enable PI and life 
long viral shedding by the animal due to development of highly virus-specific, T 
cell tolerance to the infecting strain (Collen and Morrison, 2000).Transplacental 
infection of the fetus after adaptive immune system development (beyond ~ day 
150) results in acute infection, fetal seroconversion to the infecting viral strain, 
and clearance of the virus (Done et al., 1980). PI animals are of particular 
epidemiologic significance in that they represent the reservoir of virus in the 
population and are responsible for perpetuation of the virus through infection of 
herd mates (Houe, 1999).  
 There are only a few published investigations of naturally occurring fetal 
and neonatal skeletal lesions associated with BVDV infection (Nuss et al., 2005; 
O' Connor, 1993; Scruggs, 1995). A multitude of different terms, from 
osteopetrosis to growth arrest lines, has been used in the literature to describe 
the morphologic character of skeletal lesions associated with BVDV infections. 
Experimentally produced fetal bone lesions were first described by Done et al. 
(1980) as simple growth arrest lines detected by radiography, but the distribution 
and histologic character were not described (Done et al., 1980). Another 
experimental infection, using the same viral strain used herein, noted thickening 
of the femoral cortices in PI fetuses (Smirnova et al., 2008). In one study, a 
majority of BVDV positive fetuses had fetal femora with multiple transverse zones 
of radiodensity in the metaphysis corresponding to growth retardation lattices, 
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focal radiodensities corresponding to areas of retained secondary spongiosa, 
and reduced mid-diaphyseal diameter (O' Connor, 1993).  
 Growth retardation lattices differ from simple growth arrest lines not only in 
morphologic character but also in the processes responsible for their 
development (O' Connor, 1993; Thompson, 2007). While both lesions occur in 
regionally extensive areas parallel to the physis, growth arrest lines are 
composed of increased bone volume with enhanced trabecular connectivity and 
result from impaired longitudinal growth of the physis and normal bone formation 
(Thompson, 2007). In contrast, growth retardation lattices are composed of 
increased calcified cartilage core volume, typically resulting from impaired 
resorption of calcified cartilage (Thompson, 2007).  Nuss et al. (2005) reported a 
case of transient benign osteopetrosis in a newborn calf PI with BVDV in which 
long bone metaphyses contained multiple regularly spaced, thick, transverse 
bands of radiodensity, which resolved radiographically by 5 months of age (Nuss 
et al., 2005). Although the term osteopetrosis has been used to describe skeletal 
lesions associated with BVDV (Nuss et al., 2005; Scruggs, 1995), it is probably 
more appropriately reserved for genetic diseases which result in diffuse, rather 
than zonal or cyclic, metaphyseal changes. In the previously mentioned case, 
BVDV antigen was detected by immunohistochemistry in osteoblasts, osteocytes 
and other bone marrow hematopoietic cells after necropsy at 13 months (Nuss et 
al., 2005). Unfortunately the presence or absence of BVDV antigen in osteoclasts 
was not described.  
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 Thus far, the reported lesions have been largely limited to the long bone 
metaphyses and have ranged from barely discernible growth arrest lines and 
growth retardation lattices, to diffuse and zonal retention of secondary and/or 
primary spongiosa resembling the lesions of genetic osteopetroses of cattle 
(Done et al., 1980; Nuss et al., 2005; O' Connor, 1993; Scruggs, 1995; 
Thompson, 2007). The morphogenesis of these lesions and the mechanisms 
responsible for their development is unclear.  Reduced bone and calcified 
cartilage core resorption would be the direct explanation, but contributions of 
other potential processes including enhanced bone formation or physeal 
abnormalities leading to the production of thickened primary spongiosa have not 
been investigated. Reduced bone resorption due to decreased numbers of 
osteoclasts, resulting from direct effects of virus on osteoclasts or osteoclast 
precursor cells as well as secondary effects of viral infection on such cells by 
production of interleukin 1 (IL-1) inhibitors have been suggested as possible 
molecular mechanisms (Scruggs, 1995). Reduced osteoclast numbers have 
been documented in naturally infected calves with skeletal lesions associated 
with BVDV, however no age-matched controls were available for appropriate 
comparisons (Scruggs, 1995). Decreased osteoclast numbers have been found 
in lambs experimentally infected in utero with Border disease virus (Caffrey, 
1996), a closely related Pestivirus of sheep, further lending support to the 
contention that these cells or their precursors may be selectively damaged by 
intrauterine pestiviral infections.  Taken collectively most of the previous studies 
were limited by either uncertainty in the time and course of infection, infection 
16 
status (whether subject was persistently or transiently infected) and/or by small 
numbers of affected animals (Done et al., 1980; Nuss et al., 2005; O' Connor, 
1993; Scruggs, 1995). 
 This study was undertaken to characterize the morphogenesis of long 
bone lesions over the course of experimentally induced fetal PI with BVDV in an 
attempt to determine the processes and mechanisms responsible for the 
development of these lesions.  
         
Materials and Methods 
Infection and General Growth Parameters  
 All animal experiments were approved by Colorado State University‘s 
Institutional Animal Care and Use Committee. Forty-six yearling Hereford heifers 
weighing between 295 and 430 kg were artificially inseminated with semen from 
a single Angus bull after estrus synchronization. Pregnancy was detected on day 
35 and confirmed on day 70 of gestation. All heifers were seronegative for BVDV 
type 1 and type 2 prior to infection.  Heifers were group-housed in outdoor pens. 
On day 75 of gestation, heifers (n=23) were inoculated intranasally with either 2 
ml of -MEM media containing 4.4 log10TCID50 ncpBVDV type 2 strain 96b2222 
(Van Campen et al., 2000), or -MEM media alone (n=23) to produce PI and 
control fetuses respectively, as previously described (Smirnova et al., 2008). 
Maternal infection was confirmed by detection of viral RNA in peripheral blood 
leukocytes on day 7 post infection by using semi-quantitative real time PCR (qt-
RT-PCR) as previously described (Smirnova et al., 2008), and by the presence of 
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serum neutralizing anti-BVDV2 antibodies on day 28 post infection as previously 
described (Saliki et al., 1997). Control heifers remained negative for viral RNA 
and seronegative throughout the study.   
 Eight fetuses, four infected and four controls, were collected by cesarean 
section on days 75, 82, 97, 192, and 245 of gestation. Six heifers, (3 infected and 
3 controls) received an intravenous injection of 9 mg/kg oxytetracycline (LA-200, 
Pfizer Animal Health, Exton, PA, USA) on day 175 and again on day 185 of 
gestation to flurochrome label bone formation for dynamic histomorphometry.  
Fetuses from these heifers were removed via cesarean section on day 192. 
Metaphyseal elongation rates for the proximal tibia were calculated from mid-
frontal sections of flurochrome-labeled fetuses. These calculations were 
performed by measuring the length, in four equidistant locations, of the unlabeled 
spongiosae subjacent to the physis and dividing the average length by the time 
period (7 days) between administration of the second label and collection. Body, 
liver, heart, lung, kidney, spleen, thymus, adrenal, and thyroid weights as well as 
crown-rump lengths and heart girths were recorded.  One PI fetus was lost due 
to abortion on day 230 of gestation.  
 
Radiography 
 Fetal bones were dissected free of extraneous soft tissues and digital 
radiographs were produced using a portable X-ray machine set (MinXray, 
Northbrook, IL, USA) and a digital plate system (Elikin, Carlsbad, CA, USA). 
Care was taken to precisely align limbs in the same position for these 
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radiographs. Epiphyseal and mid-diaphyseal widths and physeal to physeal 
length of the femur, tibia, humerus and radius were obtained from the 
radiographs, which contained an internal measurement standard, using 
Imagepro software (MediaCybernetics, Bethesda, MD, USA).  Measured 
parameters that differed between PI and control fetuses were confirmed by 
manual measurement with dial calipers. 
 
Histology  
 Bones were dissected free of soft tissues, fixed in 10% buffered formalin 
and cut on an ISOMET bone saw (Beuhler, Ltd Lake Bluff, IL, USA) to yield 
anatomically standardized midfrontal sections of the proximal tibial metaphysis. 
The sections were decalcified in 5% formic acid (Sigma, St. Louis, MO, USA) 
over a period of 3-7 days depending on the fetal age, before being routinely 
processed and paraffin embedded.  Five m thick sections were prepared on a 
rotary retracting microtome and stained with hematoxylin and eosin. Serial, five 
m thick sections were incubated in 0.2 M Tris-HCL, pH 9.0, solution at 37C for 
30 minutes to reactivate acid phosphatases (Liu, 1987), then stained with a 
commercial kit (Sigma, St. Louis, MO, USA) to detect cells expressing Tartrate-
resistant Acid Phosphatase (TRAP).  In addition to quantitative histology this 
approach facilitated qualitative evaluation of osteoclasts for evidence of active 
resorption in Howship‘s lacunae and number of nuclei per osteoclast as well as 
signs of degeneration or apoptosis.  
 Immunohistochemistry was performed on formalin fixed, non-decalcified, 
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paraffin embedded sections to avoid potential adverse effects of the decalcifying 
agent on viral antigen and to exactly duplicate the tissue processing utilized for 
positive and negative control tissues. Spleen and thymus from day 192 control 
and PI fetuses served as negative and positive control tissues. The combined 
effect of small, approximately 1 cm2, samples of metaphyseal bone and the low 
degree of mineralization of fetal bone at this location facilitated the production of 
high quality histologic sections using routine paraffin embedding and sectioning 
on a rotary microtome utilizing disposable blades.  The mouse monoclonal anti-
BVDV clone 15C5 (IDEXX Laboratories, Westbrook, Maine, USA) was used as 
previously described (Ellis, 1998), and staining was visualized with a Vector Elite 
kit (Vector Laboratories, Burlingame, CA, USA) as per manufacturer‘s 
recommendations.  Antigen retrieval was performed with 20 g/ml Proteinase K 
(Promega, Madison, Wisconsin, USA). 
 Formalin-fixed, facing sections of tibia that were produced during the initial 
bone sectioning were embedded in glycol methacrylate as previously described 
and sectioned on a bone saw (Maruto, Tokyo, Japan) (Huffer, 1994). The 
resulting non-decalcified semi-thin sections were ground down to 30 m 
thickness for assessment of formation parameters.   Femoral mid-diaphyseal 
cross sections were prepared by embedding the sample in Sample- Kwick® 
(Beuhler, Ltd Lake Bluff, IL, USA) and sectioning on an IsoMet® saw (Beuhler, 





Tibial sections were divided into four zones of interest as illustrated in 
Figure 1. The zones were designed such that the subphyseal zone would entirely 
encompass the primary spongiosa, which was found to not exceed 2 mm in 
length. The subjacent three zones were then determined by dividing the 
remaining metaphysis equally in thirds. 
 Histomorphometric analysis of static parameters was performed manually 
using a modified Mertz grid reticle at a standardized magnification (200x) in a 
tissue area of 4 mm2 from the central portion of each zone. Histomorphometric 
analysis of dynamic parameters was performed on a Nikon E 800 fluorescent 
microscope (Melville, NY, USA) equipped with an UV filter, using Imagepro® 
software, in a 15 mm2 area of interest from the central portion of middle and 
distal zones. The subphyseal and proximal zones were not analyzed for dynamic 
parameters due to the complete lack of labeling and predominance of diffuse 
labeling, respectively. The definition of the parameters evaluated, their 
corresponding referents, standardized nomenclature, units of measurement and 
criteria for evaluation, where applicable, are listed below: Bone volume - 
trabecular bone volume including calcified cartilage cores normalized to tissue 
volume (BV/TV, %); cartilage volume - longitudinal calcified cartilage core volume 
normalized to bone volume (Cg.V/BV, %); total bone surface (BS, mm2); number 
of osteoclasts (TRAP positive) per mm2 bone surface (N.Oc/BS, #/ mm2); 
osteoclast surface - TRAP positive osteoclast-covered bone surface normalized 
to bone surface (Oc.S/BS, %); single labeled surface - area of bone surface with  
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Figure 1. Proximal tibial metaphysis; Bovine fetus, 192 days of gestation. Subdivision of 
the proximal tibial metaphysis into zones for histomorphometry. The subphyseal zone 
extends 2 mm distal from the physeal-metaphyseal junction.  All other zones are 7 mm 




 a single  flurochrome label normalized to bone surface (s.LS/BS, %); double 
labeled surface - area of bone surface with two labels normalized to bone surface 
(d.LS/BS, %); mineralizing surface - equal to ½ the area of single labeled surface  
plus the area of double labeled surface normalized to bone surface (MS/BS, %);  
mineral apposition rate - average distance between first and second label divided 
by the number of days in the interlabel period, (MAR, m/day); and bone 
formation rate - equal to the mineralizing surface normalized to bone surface 
multiplied by the mineral apposition rate (MS/BS *MAR, mm3/mm2/day).  
 Femoral mid-diaphyseal apposition rates were determined by averaging 
the width of non-labeled subperiosteal plexiform bone at five standardized sites 
and dividing this distance by the time period (7 days) between administration of 
the second label and collection.  Hematopoietic cell density was determined by 
measuring the proportion of marrow space occupied by such cells. Proximal tibia 
physeal histomorphometry was performed on decalcified day 192 section to 
determine whether there were differences between PI and control fetuses in the 
volume and number of calcified cartilage cores being incorporated into primary 
spongiosae. The areas occupied by chondrocyte lacunae and by matrix in the 
hypertrophic zone were determined in a 4 mm2 area and expressed as a ratio. 
The number of chondrocyte columns per transverse mm of physeal width was 
determined along the central most 1 cm aspect of the physis. All bone 
histomorphometry nomenclature, units, and calculations are consistent with 




 Data were compared using Student‘s t-test or Mann-Whitney test 
depending on the result of Shapiro-Wilk test for normality. Differences at P < 0.05 
were considered significant, while differences at P < 0.10 are described as 
tendencies. Data are presented as mean  standard deviation. 
 
Results 
Infection and General Growth Parameters 
 Fetal PI was confirmed by qt-RT-PCR for BVDV RNA and 
immunohistochemical staining for BVDV antigen (Table 1). Fetuses from the PI 
group on day 82 as well as control fetuses from all collection days were negative 
for BVDV RNA and antigen. 2 out of 4 PI fetuses on day 89 were positive for 
BVDV antigen. However, one PI fetus tested positive for BVDV RNA by qtRT-
PCR (due to the technical difficulties in sample collection). All PI fetuses from 
days 97-245 were BVDV positive by both methods. 
 Crown-rump length, weight, heart girth and major organ weights did not 
differ between PI and control fetuses on any of the collection days (data not 
shown).  The fetal sex distribution by infection status was: day 192 control (3 
male, 4 female), day 192 PI (2 male, 5 female), day 245 control (2 male, 2 
female), day 245 PI (3 male, 0 female). There was no statistically significant 
effect of fetal sex on any of the study parameters reported from day 192 fetuses. 
The effect of sex on study parameters for day 245 could not be determined due 
to the lack of female fetuses in the PI group. On days 192 and 245 there was an 
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enhanced waisting or fluting of the metaphysis in PI femora characterized by 
similar physeal widths and reduced mid-diaphyseal outer diameter compared to 
controls (Table 2). This indicated that lateral appositional growth of the physis 
was not significantly impaired by PI. In mid-diaphyseal cross sections neither 
cortical thickness nor total cortical area divided by cortical diameter differed 
between the groups (Table 2). Day 192 PI fetuses had slower rates of periosteal 
apposition at this site than control fetuses, 23.6 m/day  4.7 versus 35.9 m/day 
 4.9 respectively. 
  
Table 1. Presence or absence of radiographic lesions within the tibial 
metaphyses and infection status of PI fetuses.a 
Gestational age, 







89 Days    
1   / 
2   c/ 
3   c / 
4   c / 
97 Days    
1   / 
2   / 
3   / 
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4   / 
192 Days    
1   / 
2   / 
3   / 
4   / 
5   / 
6   / 
7   / 
245 Days    
1   / 
2   / 
3   / 
a Day 82 fetuses from PI group as well as control fetuses from all time points 
were negative for virus. Controls did not have any radiographic lesions. 
b qt-RT-PCR for BVDV RNA in umbilical cord blood  and BVDV antigen in brain 
as previously described (Bielefeldt-Ohmann et al., 2012). 





















Day 82, Control 4 0.21  0.01 N/A
 
1.95  0.04 0.64  0.01 
Day 82, PI 4 0.19  0.01 N/A 1.90  0.05 0.63  0.01 
Day 89, Control 4 0.23  0.01 N/A 2.31  0.03 0.74  0.03 
Day 89, PI 4 0.23 0.02 N/A 2.28  0.03 0.71  0.02 
Day 97, Control 4 0.26  0.01 N/A 2.77  0.10 0.91  0.03 
Day 97, PI 4 0.28  0.01 N/A 2.85  0.08 0.94  .02 
Day 192, Control 7 13.4  0.34 3.51  0.53 109  2.40 34.7  1.29 
Day 192, PI 7 12.2  0.50b 3.41  0.42 107  2.53 33.6  1.46 
Day 245, Control 4 21.9  0.93 3.19  0.74 173  3.95 53.6  0.91 
Day 245, PI 3 18.6  0.71b 3.4  0.90 170  2.65 54.8  2.44 
aMean  standard deviation (mm). bDifference from control (P < 0.01). N/A - there is no definition of cortical 
thickness at days 82-97.
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Radiography  
 Radiographs of the axial skeleton, skull, and limbs were taken at each time of 
collection. No radiographic abnormalities were detected prior to day 192, after which 
they were limited to the long bones of the appendicular skeleton. Relative development 
of secondary and tertiary centers of ossification did not differ between PI and control 
fetuses. Radiographs of 6 out of 7 day 192 PI fetuses contained metaphyseal lesions. 
These consisted of focal densities in 4 out of 7 fetuses and multiple, transverse 
radiodense bands in 3 out of 7 fetuses (Figure 2, 3). Within the metaphysis the 
distribution of the focal densities appears to be random although they were most 
frequently identified within the distal femur and proximal tibia metaphyses. Radiographs 
of day 245 fetal metaphyses had similar bands of alternating radiodensity in 2 out of 3 
PI fetuses (not shown). There was marked variation amongst PI fetuses in lesion 
severity, which ranged from lesions easily appreciable to barely discernible lines. The 
distribution of such lesions between individuals differed very little. The most commonly 
affected metaphyses were distal radius, proximal tibia, distal femur, and proximal 
metacarpal/metatarsal. Radiographic lesions were not observed in the scapula or 
phalanges.  
 Metaphyseal elongation rates from day 185 to day 192 did not differ between PI 
(250  30 m/day) versus control (310  50 m/day) fetuses and were utilized to 
approximate the periods of time between the transverse bands in fetuses, which had 
easily discernable transverse bands as shown in Figure 3.  Acknowledging the non-
linear nature of long bone growth during the period of lesion development (day 97-192),  
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Figure 2. Femur, Tibia; Control bovine fetus, 192 days of gestation. Normal radiographic 
appearance of femur and tibia in control fetus. (Digital Radiograph). 
Figure 3. Femur, Tibia; PI bovine fetus, 192 days of gestation. The distal femoral and proximal 
tibial metaphyses contain multiple transverse bands of increased radiodensity and focal 
radiodensity (arrow).  Also note the reduced femoral mid-diaphyseal diameter compared to 
control (Figure 2) (arrowhead). (Digital Radiograph). 
 
bands of radiodensity were on average approximately 3-4 mm in width and would reflect 
an approximately 15 day period of growth separated by periods of 15 days or greater 
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between the bands.  
 
Histology and Histomorphometry   
 Histologic lesions and histomorphometric abnormalities were not detected prior 
to day 192, although day 97 PI fetuses had similar bone and calcified cartilage volumes, 
they tended to have fewer TRAP positive osteoclasts (N.Oc/BS, #/mm2) within the 
proximal tibia metaphysis this was not statistically significant (data not shown, P < 0.10).  
Overall the histologic lesions in PI fetuses were subtle and characterized by regionally 
extensive transverse areas of increased trabecular bone volume with increased 
amounts of longitudinal cartilage core volume and focally extensive areas of increased 
transverse connectivity between trabeculae (Figure 4-7), the former feature 
radiographically corresponded to the radiodense transverse bands and the latter to the 
focal radiodensities.  There was no difference in hematopoietic cell density between PI 
and control fetuses (data not shown).  Immunohistochemical staining for BVDV in day 
192 fetal bone sections failed to demonstrate any viral antigen within osteoclasts or 
bone forming cells (data not shown). 
 Histomorphometric parameters from the proximal tibial metaphyses of day 192 
fetuses are detailed by zone in Table 3.  Analysis by zone demonstrated increased 
bone volume within the middle and distal zones of PI tibia as well as increased cartilage 
core volume within the distal zone. Within the proximal zone, there were decreased 
numbers of TRAP positive osteoclasts and reduced TRAP positive osteoclast surface 




Figure 4. Proximal tibial metaphysis; Control bovine fetus, 192 days of gestation. Normal 
trabecular bone volume in control fetus. (H&E). 
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Figure 5. Proximal tibial metaphysis; PI bovine fetus, 192 days of gestation. There is increased 
volume of trabecular bone compared to control (Figure 4). (H&E).  
 
Figure 6. Higher magnification photomicrograph of Figure 4. Normal volumes of longitudinal 
cartilage cores and trabecular bone in control fetus. (H&E). 
 
Figure 7. Higher magnification photomicrograph of Figure 5. The volume of longitudinal cartilage 
cores is increased relative to the volume of trabecular bone compared to control. (H&E).  
 
Figure 8. Proximal tibial metaphysis; Control bovine fetus, 192 days of gestation. Normal 
flurochrome labeling (thin, single and double greenish-gold lines) in control fetus. (Giemsa 
stained, oxytetracycline labeled, undecalcified, 30 µm thick ground sections under UV light).   
 
Figure 9. Proximal tibial metaphysis; PI bovine fetus, 192 days of gestation. There is markedly 
reduced extent of flurochrome labeling (thin, single and double greenish-gold lines) compared to 
control (Figure 8). (Giemsa stained, oxytetracycline labeled, undecalcified, 30 µm thick ground 
sections under UV light).   
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Table 3. Static histomorphometric parameters from proximal tibia metaphysis of day 192 Control and PI fetuses by 
zone.a  
Zone Subphyseal Proximal Middle Distal 
 Control PI Control PI Control PI Control PI 









































































aMean  standard deviation (N = 7 Control, N = 7 PI). bP < 0.05. cP < 0.01. 
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Collectively, when all zones were pooled and evaluated as one zone of interest, PI tibia 
had increased bone volume and cartilage core volume with decreased number of TRAP 
positive osteoclasts and TRAP positive osteoclast surface. Qualitatively, osteoclasts 
from PI tibia were present both within deep Howship‘s lacunae and on crenated 
surfaces and did not differ in morphologic character or number of nuclei per osteoclast 
to those from control tibia. Histologic features of degeneration, necrosis, or apoptosis 
were not identified in osteoclasts or hematopoietic cells at any time point evaluated. In 
the evaluation of the physis at its junction with the metaphysis there were no differences 
in the mean number of chondrocyte columns per transverse mm of physeal-
metaphyseal junction, 24.4 ± 1.5 versus 23.7 ± 1.0, control versus respectively or 
chondrocyte lacunar area to matrix area ratios, 1.6 ± 0.4 versus 1.3 ± 0.3, between 
control and PI fetuses.  
 Bone formation parameters in the middle and distal zones from the proximal tibial 
metaphyses of day 192 fetuses are shown in Table 4. The majority of flurochrome 
labeled bone surface was diffusely labeled, but a considerable amount of discrete single 
and double labels were present to facilitate analysis (Figure 8,9). Single labeled surface 
was less within the distal zone as was double labeled surface within the middle zone of 
PI tibias. Mineralizing surface was less in PI tibia within both zones. There was no 
difference in mineral apposition rates in either zone. However, bone formation rates 
were slower within the distal zone of PI tibia. Collectively when the middle and distal 
zones were pooled and evaluated as one zone of interest there was decreased single 
labeled surface, double labeled surface, and mineralizing surface in PI fetuses when 
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Table 4.  Dynamic histomorphometric parameters from proximal tibia metaphysis of day 192 fetuses by zonea. 
Zone Middle Distal 
 Control PI Control PI 
Single Labeled Surface, 
sL.S/BS (%) 
23.2  4.5 20.3  0.9 16.5  1.5 9.6  2.8b 
Double Labeled Surface, 
dL.S/BS (%)  
9.7  1.7 4.8  1.0b 5.5  3.0  1.5  0.7 
Mineralizing Surface, 
MS/BS (%) 
21.4  2.8 15.0  1.0b 13.7  2.8 6.3  1.9b 
Mineral Apposition Rate, 
MAR (m/day) 
0.62  0.12 0.64  0.10 0.66  0.16 0.51  0.14 
Bone Formation Rate, 
BAR (m3/m2/day) 
0.14  0.04 0.10  0.01 0.09  0.03 0.03  0.01b 
aMean  standard deviation (N = 3 control and N = 3 PI). bP <0.05.  
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compared to control fetuses.  Bone formation rates tended to be slower in PI tibia 




 The two major findings that emerged from this study were the negative 
impact of PI on both tissue level bone formation in trabecular and cortical bone 
as well as on trabecular modeling. The histomorphometric parameters correlated 
well with the radiographic findings.  The majority of radiodense transverse bands 
were present within the middle and distal zones where increased bone and 
cartilage core area were found. The increased radiodensity of these bands was 
associated with increased volumes ofcalcified cartilage and bone, the former 
contributing to the radiographic appearance of the bands due to its greater 
radiodensity relative to immature bone (Eisenstein, 1975).  
 In order for greater cartilage core volume to be present distally in the 
metaphysis, cartilage resorption must have been impaired during the initial 
modeling of these trabeculae. It is hypothesized that in the primary spongiosa a 
lesser amount of residual intercolumnar cartilage was resorbed before osteoid 
formation commenced. The alternative possibility is that the increased volume 
results directly from an increased volume of intercolumnar matrix with a lower 
lacunar:matrix ratio and less chondrocyte column density in the physis.  The 
physeal morphometry results support the former hypothesis as there was no 
difference in these parameters between PI and control fetuses at the time of 
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sample collection. The periodicity of transverse bands certainly suggests a cyclic 
insult or physiologic alteration that manifests through reduced trabecular 
modeling of primary spongiosa.  The transverse bands reflect a period of 
approximately 15 days of ‗normal‘ modeling in between periods of approximately 
15 days of abnormal modeling. This time period is based on our estimate of 
metaphyseal elongation rates and the assumption that they are not altered by 
this process. The reason trabecular modeling resumes normally in between 
these insults is not known. However, the cyclic nature of the lesions significantly 
enhances the difficulty of studying the morphogenesis of these lesions, as 
lesions did not appear within the same region or occur during the same 
developmental time within all fetuses. For example, a specific metaphyseal zone 
from a particular PI fetus may contain no bands, when the same zone of another 
PI contains one or two.  
 Metaphyseal lesions have been described in association with a variety of 
different viral infections in growing animals. Growth retardation lattices similar to 
those found in this study have been described in growing dogs infected with 
canine distemper virus (Baumgartner, 1995), in cats infected with feline 
herpesvirus (Hoover, 1971), in sheep infected with border disease virus (Caffrey, 
1996), and in pigs which survive acute infections with classical swine fever virus 
(Thompson, 2007).  In contrast to the lesions described in this study, the growth 
retardation lattices caused by viral infections in other species are typically 
singular and lack the cyclic nature characterized herein.  The pathogenesis of 
metaphyseal lesions caused by other pestiviruses, border disease virus and 
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classical swine fever virus, may be similar to those described in this study, while 
growth retardation lattices due to feline herpesvirus and canine distemper virus 
infections appear to be due to the direct effect of these viruses on osteoclast 
resulting in osteoclast necrosis during the acute phase of infection (Baumgartner, 
1995; Hoover, 1971).  
 Abnormal trabecular modeling can result from altered osteoclast 
production, function, migration and survival, all of which can manifest as similar 
histomorphometric findings. The morphologic changes do not appear to be due 
to decreased osteoclast survival as evidenced by the lack of osteoclast apoptosis 
or necrosis and similar numbers of osteoclast nuclei per osteoclast at all study 
time points. Osteoclast function appears to be normal in PI fetuses with 
osteoclasts being found on crenated surface and deep within Howship‘s lacunae. 
Likewise osteoclast migration did not appear to be altered, as osteoclasts were 
present in similar numbers at the leading edge of vascular growth at the physis. 
Regardless of these observations, the cyclic nature of these lesions would 
necessitate evaluation of samples from additional time points in the period 
between day 97 and 192 as well as application of specific assays to determine 
the cause with any certainty. Reduced numbers of osteoclasts found in the 
proximal zone of PI tibias are presumably responsible for the abnormal modeling 
but the reason for this is not clear. Impaired osteoclast differentiation is a 
possible explanation and investigation of this process may aid in explaining the 
time course of the cyclic nature of these lesions.  It has been well established for 
some time that the osteoclasts are derived from bone marrow precursor cells of 
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the monocytic linage (Jotereau; Khan, 1975; Sminia, 1986). Although the time 
required for generation of functional osteoclasts from permissive precursor cells 
in the bovine fetus is unknown estimates from in vitro experiments in other 
species suggest that it ranges from 14-21 days for humans and approximately 11 
days for mice (Duplomb, 2007; Sivagurunathan, 2005). This time course of 
development would appear to correlate with the estimated period of 15 days 
determined in this study.    
 PI with BVDV may impair osteoclast differentiation either due to a direct 
effect of viral infection on precursor cells or as a secondary effect as a result of 
the action of cytokines. Monocytes infected in vitro with BVDV have been shown 
to release an IL-1 inhibitor (Jensen, 1991). Inhibition of IL-1 activity, which 
positively regulates osteoclastogenesis (Kim, 2009), has been postulated to be 
responsible for impaired osteoclast differentiation in PI animals (Scruggs, 1995) 
PI fetuses have been shown to have a chronic moderate IFN-I response 
(Smirnova et al., 2008), and it is plausible that chronic production of IFN , a 
potent negative regulator of osteoclast differentiation (Takayanagi, 2005), 
negatively impacts osteoclastogenesis.  
 BVDV is known to infect cells of the innate immune system including, 
monocytes, macrophages and dendritic cells (Sopp, 1994). Recent studies have 
demonstrated that BVDV infected monocyte-derived macrophages have 
significantly impaired functional capacity, as measured by phagocytosis and 
cytokine production in vitro (Chase et al., 2004; Peterhans et al., 2003). Because 
macrophages and osteoclasts originate from a common precursor cell, both cell 
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types may be affected by a similar mechanism. Similar to the findings of others 
(Nuss et al., 2005; Scruggs, 1995), attempts to demonstrate BVDV antigen in 
osteoclasts by immunohistochemical methods were not successful even though 
positive control tissues from other organs that were processed in the same 
manner as the bone sections resulted in positive staining. The reason for this is 
unclear but may be due to the amount of virus present being below the threshold 
of detection or absence of viral antigen altogether within osteoclasts. 
 The second important finding was reduced tissue level bone formation in 
PI fetuses suggesting a decrease in the extent of osteoblast surface actively 
involved in bone formation.  The cell level parameter of bone formation, mineral 
apposition rate appeared to be normal, suggesting that PI either impairs 
recruitment of osteoblasts into active formation or there is cyclic impairment of 
cell level bone formation not apparent in the intra-labeling period (days 175-185). 
Other investigators have reported the presence of BVDV antigen in osteoblasts 
and osteocytes (Nuss et al., 2005), but this was not corroborated in present 
study. Thus the potential primary effect of ncpBVDV on bone forming cells is 
uncertain. However, BVDV infection of osteoblasts could impact 
osteoclastogenesis indirectly through impaired receptor activator for nuclear 
factor kappa B (RANK) signaling and provide an alternative explanation for the 
observed effects on both cell types. 
 One common theme throughout this study was the marked individual 
variation in parameters measured and lesion severity. Certainly one of the most 
important contributing factors was the cyclic nature of the lesions, which 
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inevitably resulted in some PI fetuses demonstrating features of normal modeling 
while other features of abnormal modeling both within the same anatomic region 
of the metaphysis. It would appear that this reflects inherent individual biological 
variation or possibly a complex combination of undetermined factors that may 
have further contributed to the variation in the degree of lesion severity. This was 
a consideration in focusing the study on the day 192 fetuses because they 
possessed the most severe radiographic lesions and a superior sample size 
when compared to other collection times.   
 In summary, PI of bovine fetuses with ncpBVDV results in decreased 
numbers of osteoclasts, which impair trabecular bone modeling in a cyclic 
fashion. Experiments aimed at clarifying the mechanisms responsible for 
decreased osteoclast numbers in PI are underway. Additionally, PI impairs tissue 
level bone formation activity in the trabecular and cortical envelopes. These 
results may provide one explanation for the growth abnormalities observed in PI 
cattle. To the authors‘ knowledge this study provides novel insight as to the time 
of occurrence of long bone lesion during development in PI, the variable 
presences and severity of such lesions and their cyclic nature with an estimation 
of the duration of the period of abnormal modeling. It is also the first study to 
demonstrate the successful use of in vivo flurochrome labeling of fetal bone, via 







THE EFFECTS OF IN UTERO PESTIVIRUS INFECTION ON BONE 
GEOMETRY, BIOMECHANICAL PROPERTIES AND COMPOSITION OF 
BOVINE FETAL FEMORA 
 
Introduction 
 Fetal bone development involves a complex series of processes working 
in concert to produce substantial longitudinal and appositional growth of the 
organ in a relatively short period of time. Inherently these conditions enhance the 
sensitivity of the organ to intrauterine insults, which can lead to abnormal bone 
growth and may impair neonatal bone function.  Viral infections represent unique 
developmental insults that can result in growth restriction of the fetus and 
abnormal bone development in domesticated animals and humans (Graham et 
al., 1970; Smirnova et al., 2008; Williams and Carey, 1966) The effects of such 
infections on the skeleton remain largely unknown for a majority of the most 
common viruses with demonstrated ability to cross the placenta and infect the 
developing fetus. Transplacental infection with human cytomegalovirus and 
Rubella virus can result in abnormal fetal bone development, characterized by 
the development of irregular radiodense zones within the metaphyses, and are 
frequently associated with pathologic fractures in the neonate (Graham et al., 
1970; Kopelman et al., 1972; Sacks and Habermann, 1977; Smith and Specht, 
1979; Williams and Carey, 1966). To our knowledge the effects of intrauterine 
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viral infections on the biomechanical properties of fetal bone have not been 
investigated in any species. 
 Bovine viral diarrhea virus (BVDV), family Flaviviridae, is an important 
cause of viral disease in cattle and is capable of causing transplacental infection 
of the fetus.  Noncytopathic biotypes of BVDV are characterized by the inability to 
cause cytopathogenicity in cell culture and able to cause persistent infection (PI) 
of the fetus. If maternal infection occurs prior to the development of fetal adaptive 
immunity, the fetus can become PI leading to lifelong viral shedding in the 
animal.  PI with BVDV results in impaired fetal bone development characterized 
by the development of regularly spaced transverse radiodense bands within long 
bone metaphyses (Nuss et al., 2005; Webb et al., 2012). The radiodense bands 
represent growth retardation lattices, which are formed as a result of impaired 
modeling of primary spongiosa secondary to reduced numbers of osteoclasts,  
and are similar in morphology to lesions caused by congenital Rubella virus and 
cytomegalovirus infections in humans (Webb et al., 2012). PI with BVDV also 
results in impaired tissue level bone growth with one such manifestation being 
reduced periosteal apposition rates which lead to reduced femoral mid-
diaphyseal diameter in affected fetuses (Webb et al., 2012) A reduction in mid-
diaphyseal diameter lends a more fluted appearance to the metaphysis of PI long 
bones because epiphyseal diameter and overall bone length are not significantly 
affected.  
 Bone fragility has been previously suspected as the underlying cause of 
neonatal calf long bone fractures associated with transplacental infection with 
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BVDV (Constable et al., 1993; Nuss et al., 2005; O'Toole, 2006). Based on these 
findings it was hypothesized that bones from PI fetuses would have impaired 
biomechanical properties. This study was undertaken to characterize the 
biomechanical effects of intrauterine viral infections, specifically PI with BVDV, on 
fetal femora and determine the architectural and/or compositional factors 
responsible for any potential differences in mechanical properties.   
 
Materials and Methods 
Fetal Infection 
All animal experiments were approved by the Colorado State University 
Animal Care and Use Committee. BVDV-naïve Hereford heifers (n=19), ranging 
in weight from 295 to 430 kg, were estrus-synchronized and artificially 
inseminated with BVDV-free semen from a single Angus bull.  After confirmation 
of pregnancy on day 35 of gestation, heifers were inoculated intranasally on day 
75 of gestation with either 2 ml of MEM media containing 4.4 log10TCID50 
noncytopathic BVDV type 2 strain 96b2222 (Van Campen et al., 2000), or MEM 
media alone to produce PI and Control fetuses. Six pregnant heifers (n=3 
Control, n=3 PI) received intravenous injections of oxytetracycline (9 mg/kg) on 
days 175 and 185 of gestation to fluorochrome label fetal bone formation. 
Fetuses from the fluorochrome labeled group were collected via Cesarean 
section on day 192 of gestation.  The remaining non-labeled fetuses were 
collected via Cesarean section on days 192 (n=4 Control, n=2 PI) and 245 (n=4 
Control, n=3 PI) of gestation. Following delivery of the fetus from the uterus, the 
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fetuses were immediately euthanized with an overdose of sodium pentobarbital.  
Fetal PI was confirmed by qRT-PCR for viral RNA in fetal blood as previously 
described (Smirnova et al., 2008).  
Following euthanasia, left femora were dissected free of soft tissue with 
care taken to leave the periosteum intact, then wrapped in saline soaked gauze 
and frozen for later mechanical testing. Right femora were dissected free of soft 
tissue and fixed in 10% neutral buffered formalin. The overall length of the left 
femora from the articular surface of the medial condyle to the articular surface of 
the femoral head and width of the distal epiphysis at its widest point in the 
mediolateral plane were recorded. Right femora were then transversely 
sectioned at the mid-diaphysis and diaphyseal diameter in the medial to lateral 
and cranial to caudal axis and cortical thickness at five standardized sites were 
measured with dial calipers.  Average mid-diaphyseal diameter divided by overall 
length and average mid-diaphyseal diameter divided by width at the distal 
epiphysis were used as indexes of bone geometry. Total cross-sectional area 
and cortical thickness ratio were calculated, the latter using the following formula: 
2 * average cortical thickness/ average diaphyseal diameter as previously 
described (van Lenthe et al., 2008).  
 
Mechanical Testing 
Mechanical testing was performed on a servohydraulic mechanical testing 
system (858 Mini Bionix II, MTS, Eden Prairie, MN) utilizing a custom-built four-
point bending fixture. Femora were thawed at 4C for 1-2 days and brought to 
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room temperature immediately before mechanical testing. Since there was no 
significant difference in length between control and PI femora at either day of 
collection, standardize fixture settings were used for each collection day. The 
distance between fixture contacts were as follows: for day 192 fetuses outer 
contacts were spaced 41 mm apart and inner contacts 22 mm apart, for day 245 
fetuses outer contacts were spaced 73 mm apart and inner contacts 48 mm 
apart.  Whole femora were preconditioned by two cycles of loading to 150 N at a 
crosshead displacement rate of 0.15 mm/second. Femora were then loaded in 
four-point bending until failure in the cranial to caudal axis at a crosshead 
displacement rate of 0.15 mm/second. Force and displacement were recorded at 
100 Hz with custom software. Strain and stress were calculated from standard 
beam bending equations for four-point bending of a cylindrical tube:  Stress =
, and strain = , where a is the distance between the outer 
and inner contacts, c is equal to one-half femoral diameter, I is the area of the 
moment of inertia, d is the displacement and l is the distance between the outer 
contacts (Turner and Burr, 1993). Stiffness was calculated by determining the 
slope of the linear regression fit of the force displacement curve at three linear 
segments of the curve, which corresponded to 100-500 N, 500-900 N, and 900-
1300 N of force. Elastic modulus was determined by the slope of the linear 














Mid-diaphyseal sections of right femora were embedded in an epoxy resin 
(Sampl-Kwick, Buehler Ltd, Lake Bluff, IL) and cut on a low speed saw (ISOMET 
saw, Buehler Ltd, Lake Bluff, IL) equipped with a diamond blade to yield 250-400 
m thick sections. The resulting sections were hand ground to 100  20 m 
thickness for light microscopic evaluation.  Fluorochrome labeled sections were 
used to determine the portion of the outer cortex containing plexiform bone 
capable of chelating fluorochrome within the woven bone cores.  This proportion, 
which represents a measure of the amount of newly mineralized bone within the 
cortex, was determined at four standardized sites by measuring from the 
endocortical aspect of the first label to the periosteal surface and dividing by 
cortical thickness (Figure 10).   
 
Figure 10. Cross section of femoral cortex from oxytetracycline-labeled day 192 fetus 
depicting greenish-gold oxytetracycline label within woven bone cores of outer plexiform 
bone. First label, day 175 of gestation (thin double-headed arrow), second label, day 185 
of gestation (thick double-headed arrow), site of measurement for determining portion of 
newly mineralized cortex (longer line) extends from the periosteal surface to the 
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endocortical aspect of the first label. Measurement bar = 0.5 mm. Unstained, 100 m 
thick section under UV light. 
 
Average plexiform plate separation was determined by averaging the 
distance from the osteoid surface to the osteoid surface of the adjacent plate for 
the four outermost plexiform plates at four standardized sites. Cortical porosity 
was determined using a modified Mertz grid and simple point counting method 
under 200 x magnification at four anatomically standardized areas of interest, 
which extended from the periosteum to endocortical surface.  The size of the 
areas of interest inherently varied due to differences in cortical thickness, but was 
on average 1.1 mm2 for day 192 fetuses and 1.2 mm2 for day 245 fetuses.  
 
Ash and Mineral Analysis 
Ash and mineral analysis was performed on cortical bone from the left 
femora (mechanically tested femur) utilizing previously described analytical 
methods (Norrdin et al., 1977). A transverse section of mid-diaphysis measuring 
approximately 5 mm in width was ashed and calcium (Ca) and phosphorus (P) 
content were determined.  Tissue volume (cortical cross-sectional area  slice 
thickness), ash density (g ash/ cm3 tissue volume  (1 - porosity), apparent 
density (g ash/cm3 tissue volume), percent calcium (g Ca/g ash weight), percent 






Data analysis was performed with SAS statistical software (SAS Institute 
Inc., Cary, NC) using the General Linear Models procedure. Comparisons were 
performed with the least square means procedure followed by Student‘s t- test. 
For mechanical data, linear regression analysis was used to determine the effect 
of independent variables.  All data are presented as mean  standard deviation 
and assumptions for use of applicable statistical tests were satisfactorily met. All 
differences described were significant at the P < 0.05 level and tendencies at the 
P < 0.10 level. 
 
Results 
All PI fetuses from both days of collection were positive and all Control 
fetuses were negative for BVDV RNA in blood by qRT-PCR (Bielefeldt-Ohmann 
et al., 2012). There was no difference in body weight between Control and PI 
fetuses (Table 5). Fetal sex by day of collection was recorded: day 192 Control (3 
males, 4 females), day 192 PI (1 male, 4 females), day 245 Control (2 males, 2 
females), day 245 PI (3 males).   The long bones of three out of five PI fetuses 
on day 192 and two out of three PI fetuses on day 245 contained radiographic 
lesions consisting of focal densities and transverse radiodense bands within 
metaphyses as previously described (Webb et al., 2012).  
Femoral dimensions appear in Table 5. PI fetuses had smaller mid-diaphyseal 
diameters when compared to Control fetuses. Overall femur length and width at 
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the distal epiphyses did not differ between PI and Control fetuses, although there 
was a tendency for overall length to be less in day 192 PI compared to Control 
fetuses. The two indexes of bone geometry, mid-diaphyseal diameter/length and 
mid/diaphyseal diameter/width at distal epiphysis, were lower in PI versus 
Control fetuses on both collection days. This confirmed the gross observation 
that the bones of PI fetuses have a more accentuated taper from the epiphysis to 
the diaphysis. Mid-diaphyseal cortical thickness did not differ between PI and 
Control fetuses, but total cortical cross- sectional area was less in PI fetuses 
compared to respective groups on day 192. Control and PI fetal femora fromboth 
days of collection consistently failed between the inner contacts of the testing 
fixture.  The most common fracture configuration was a short oblique fracture 
located slightly proximal to the mid-diaphysis. There were no differences in 
fracture configuration or site of fracture between Control and PI fetuses on either 
day of collection.   
Results of the four-point bending test are presented in Table 6.  Neither 
force at failure nor displacement at failure differed between PI and Control 
fetuses on either day but there was a tendency for force at failure to increase 
from day 192 to day 245 in the PI group. Displacement at failure increased in 
both groups from day 192 to day 245. Overall slope of the force versus 
displacement plot (stiffness) was greater in day 192 fetuses compared to older 
fetuses (Figure 11 A, P < 0.01) even though individual values of stiffness, in 
different load ranges, only differed with age in Control fetuses at 500-900N of 
load.  When stiffness was plotted against cortical thickness ratio there was
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Table 5. Body weight and femoral dimensions of Control and PI fetuses on days 192 and 245 of gestation. (Mean  
standard deviation) 
 192 Days  245 Days 
Parameter (units) Control PI Control PI 
Number of fetuses 7 5 4 3 
Body weight, (kg) 9.04  0.76 8.01 1.08 25.34  0.40 24.83 1.80 
Femoral length, (cm) 10.94  0.40 10.63  0.27a 17.33  0.39 17.00 0.26 
Cranial-caudal mid-diaphyseal 
diameter, (mm)  
13.20  0.31 11.76  0.32b 21.48  1.44 18.47  0.91b 
Medial-lateral mid-diaphyseal 
diameter, (mm) 
13.50  0.43 12.22  0.49b 22.28  0.49 18.73  0.51b 
Mid-diaphyseal diameter/length 0.122  0.004 0.113  0.004b 0.126  0.006 0.109  0.004b 
Mid-diaphyseal diameter / Width 
at distal epiphysis 
0.385  0.014 0.361  0.014b 0.408  0.011c 0.340  0.007b,d 
Mid-diaphyseal cortical 
thickness, (mm) 
3.51  0.53 3.44  0.46 3.19  0.74 3.41  0.90 
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Total cortical cross sectional 
area, (mm2) 
108.14  13.22 91.97  9.78b 184.35  28.04 161.50  38.02 
Cortical thickness ratioe 0.52  0.07 0.57  0.07 0.29  0.08c 0.37  0.07c 
a Tendency for difference from age matched control P < 0.10.   
b Difference from age matched control P < 0.05.  
c Difference from day 192 vs. day 245 of same infection status, P < 0.05 
d Tendency for difference from day 192 vs. day 245 of same infection status P < 0.10. 
e See Materials and Methods for formula. 
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significant positive correlation (Figure 11 B, R2 = 0.49, P < 0.01).  After correcting 
stiffness for bone size, day 192 PI fetuses had greater elastic modulus than 
respective controls at all load levels examined and day 245 PI fetuses tended to 
have a higher elastic modulus from 500-900 N and from 900-1300 N loads. 
Elastic modulus decreased from day 192 to day 245 within both groups. Elastic 
modulus plotted against cortical thickness ratio demonstrated significant 
linearcorrelation with an individual distribution similar to that of Figure 11 B 
(Figure 12 A, R2 = 0.48, P < 0.001). Elastic modulus when plotted against mid-
diaphyseal diameter/length revealed two populations that appeared to separate 
based on fetal age and infection status. The resulting regression lines of day 192 
fetuses versus day 245 fetuses in this plot differed both in slope and intercept 
(See Figure 12 B, P < 0.05). When force at failure was normalized to bone area, 
ultimate stress tended to be greater in day 245 PI fetuses compared to age 
matched controls, but did not differ in day 192 PI fetuses versus day 192 
controls. Ultimate stress was lower in both Control and PI fetuses on day 245 
when compared to respective groups on day 192 (Table 6), but showed 
significant linear correlation with cortical thickness ratio (See Figure 12 C, R2 = 
0.65, P < 0.001). Ultimate stress was lower in both Control and PI fetuses on day 
245 when compared to respective groups on day 192 (Table 6), but showed 
significant linear correlation with cortical thickness ratio (See Figure 12 C, R2 = 




Table 6. Four-point bending test of femora from Control and PI fetuses on days 192 and 245 of gestation. (Mean  
standard deviation) 
 192 Days 245 Days 
Parameter (units) Control PI Control PI 
Displacement at failure, (mm) 4.19  0.36 3.84  0.32 8.6  1.73a 10.10  1.58a 
Force at failure, (N) 2627  890 2126  359 3162  372 3510  1300b 
Stiffness (N/mm), @ 100-500 N 582  88 574  88 510  44 481  194 
Stiffness (N/mm), @ 500-900 N 759  155 800  244 480  96a 704  246 
Stiffness (N/mm), @ 900-1300 N 837  241 803  177 578  106 705  357 
Elastic modulus, (MPa), @ 100-
500 N  
252.57  42.8 377.92  83.4c 141.7  12.9a 197.3  64.1a 
Elastic modulus, (MPa), @ 500-
900 N 
328.10  66.1 500.54  108.2c 133.6  26.7a 255.8  76.9a,b 
Elastic modulus, (MPa), @ 900-
1300 N  
361.53  106.1 519.36  72.2c 160.8  31.3a 275.8  96.0a,b 
Ultimate stress, (MPa) 55.71  16.2 61.07  7.7  26.59  2.5a 42.75  12.5a 
54 
a Difference,  day 192 vs. day 245 of same infection status, P < 0.05. 
b Tendency for difference from age matched control, P < 0.10.   
c Difference, age matched control P < 0.01.  
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 Figure 11.  (A) Force versus displacement plot for control and PI fetal femora on days 
192 and 245 of gestation.  Control and PI femora on day 192 have greater slope 
(stiffness) when compared to their respective groups on day 245 (P < 0.01). (mean  
standard deviation) (B) Stiffness versus cortical thickness ratio plot for control and PI 
fetal femora on days 192 and 245 of gestation.  There is significant positive linear 






Figure 12.  (A) Elastic modulus versus cortical thickness ratio plot for control and PI fetal 
femora on days 192 and 245 of gestation.  There is significant positive linear correlation 
between elastic modulus and cortical thickness ratio (R2 = 0.48, P < 0.001). (B) Elastic 
modulus versus mid-diaphyseal diameter/length plot for control and PI fetal femora on 
days 192 and 245 of gestation. The regression lines for day 192 versus day 245 fetuses 
differ in slope and intercept (both P < 0.05). (C) Ultimate stress versus cortical thickness 
ratio plot for control and PI fetal femora on days 192 and 245 of gestation. There is 
significant positive linear correlation between ultimate stress and cortical thickness ratio 
(R2 = 0.65, P < 0.001). 
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Morphometry and compositional data from the femoral mid-diaphyseal 
cortex appears in Table 7. There was no difference in the percent of 
fluorochrome labeled cortex between Control and PI fetuses on day 192. PI 
fetuses on day 192 had shorter average separation of plexiform plates compared 
to Controls, as did day 245 Control fetuses compared to day 192 Control fetuses. 
Cortical porosity was less in PI fetuses on both days 192 and 245 when 
compared to respective age controls, but did not change from day 192 to day 245 
in either group. There was no significant linear correlation between porosity and 
elastic modulus nor ultimate stress, or between average separation of plexiform 
plates and elastic modulus or ultimate stress.  
 There was no difference in apparent density, ash density, percent calcium, 
percent phosphorus, or Ca:P molar ratio between PI and Control fetuses on 
either day of collection or between fetuses from day 192 compared to day 245.   
 
Discussion  
The first objective of this study was to determine if in utero infection with BVDV 
impaired the biomechanical properties of fetal femora. Elastic modulus increased 
as a result of PI but decreased in older fetuses (Table 6.) Ultimate stress also 
decreased in older fetuses. A plot of ultimate stress versus elastic modulus 
showed good linear correlation (data not shown), suggesting that the values are 
proportionally in line with previous studies (Currey, 1999). Collectively these 
results suggest that the strength and elastic modulus of fetal bone decreases in  
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Table 7. Morphometry and Compositional data from the femoral cortex of Control 
and PI fetuses on days 192 and 245 of gestation. (Mean  standard deviation) 
 
Parameter (units) 
192 Days 245 Days 
Control PI Control PI 
Labeled cortex, (%)a 36.1  8.8 36.2  20.6 N/F N/F 
Plexiform plate separation, 
(m)a 
139  11 124  10b 118  8c 114  15 
Porosity, (%) 34.2  4.9 26.8  3.7b 30.0  1.7  25.6  1.3b 
Apparent density, (g/cm3)a 1.00  0.09 1.02  0.06 0.96  0.06 1.13  0.21 
Ash density, (g/cm3)a 1.04  0.11 0.94  0.09 0.91  0.04 1.03  0.20 
Calcium, (%) 24.1  1.4 25.1  1.4 27.5  6.2 24.6  0.4 
Phosphorus, (%) 11.0  1.8 11.4  2.0 12.0  0.5 11.8  0.5  
Ca:P  (M/M) 1.74  0.37 1.74  0.32 1.78  0.45 1.62  0.04 
a See Materials and Methods for formulae. 
b Difference from age matched control P < 0.05. 
c Difference from day 192 vs. day 245 of same infection status, P < 0.01. 
N/F – not flurochrome labeled. 
 
the third trimester of gestation and that PI with BVDV results in increased elastic 
modulus.   
Major architectural and compositional determinants of elastic modulus 
were evaluated in an attempt to determine the cause of increased elastic 
modulus in PI fetuses and to gain an understanding of why both strength and 
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elastic modulus decreased with age. Because fetal cortical bone is more 
heterogeneous in architecture and in degree of mineralization than cortical bone 
of skeletally mature animals, oxytetracycline labeling was used to evaluate 
variations in anatomic distribution of bone with varying degrees of mineralization.  
The percent of labeled cortex which represents the portion of bone, which is still 
in the process of mineralization and able to chelate oxytetracycline label did not 
differ between PI and Control fetuses. Significant differences in average 
separation of plexiform plates and porosity were found between PI and Control 
fetuses. There was no difference in ash or mineral composition between any of 
the groups.   These findings demonstrate that there were no significant 
quantitative differences in cortical mineralization between PI and Control fetuses. 
All of these factors failed to correlate statistically with elastic modulus and thus 
explain the observed difference.  Furthermore, there were no significant 
differences in these factors to explain the differences in biomechanical properties 
between day 192 and day 245 fetuses. While it is reasonable to presume that 
each of these factors do make small contributions to material properties, the 
sample size of this study was not large enough to provide sufficient statistical 
power in a more complex statistical model that would enable these lesser 
contributions to be defined. 
 The only significant gross morphologic difference between PI and Control 
fetuses in this study was mid-diaphyseal diameter.  Cortical thickness, cortical 
thickness ratio, overall bone length and width of the distal physis did not differ. 
The cause of impaired femoral periosteal apposition rates (Webb et al., 2012), 
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and thus reduced diameter, in PI fetuses is unknown, but the fact that cell level 
osteoblastic bone formation is reportedly normal in these fetuses suggests that 
there is defective recruitment or differentiation of osteoblasts into active bone 
forming cells (Webb et al., 2012).  
As our samples differed significantly in diameter we investigated the 
relationship of bone geometry and biomechanical parameters, which were found 
to differ. Unexpectedly, there was a profound effect of cortical geometry on 
elastic modulus, with cortical thickness ratio accounting for approximately 49% of 
the difference in elastic modulus that was observed between the groups. 
Differences in elastic modulus between day 192 and day 245 fetuses were 
largely explained by differences in bone geometry (mid-diaphyseal diameter) 
(regression analysis not shown), although there appears to be a disproportionate 
effect on modulus in day 192 versus day 245 fetuses as described by the 
differences in regression line slope and intercept between fetal age (Figure 12 
B).  Cortical geometry (cortical thickness ratio) accounted for approximately 65% 
of the difference in decreased ultimate stress in day 245 fetuses (Figure 12 C)  
The idea that cortical geometry can have significant influence on area 
normalized biomechanical parameters such as elastic modulus is not a novel 
contention and has been described by others (Akhter et al., 2004; Silva et al., 
2004; van Lenthe et al., 2008). One study evaluating the effect of cortical 
thickness ratio on elastic modulus values as calculated by beam theory 
equations in three-point bending found that elastic modulus was disproportionally 
affected by differences in bone geometry (van Lenthe et al., 2008). The 
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specimens tested in this study differed significantly in cortical thickness ratio 
which was similar to that observed between day 192 versus day 245 fetuses 
tested herein.   However we demonstrated differences in elastic modulus 
between PI versus Control which had similar cortical thickness ratios and differed 
only in mid-diaphyseal diameter. These results suggest that differences in 
cortical diameter can have a similar affect on modulus values even when cortical 
thickness ratios are similar.  
 At least in humans, cattle and some strains of mice, bone geometry 
changes with age such that the mid-diaphyseal diameter increases to a much 
greater degree than cortical thickness (Land and Schoenau, 2008; Silva et al., 
2002). Compared to calculation of elastic modulus by different methods such as 
finite element analysis modeling, calculation by classical beam theory has been 
found to significantly underestimate modulus values (van Lenthe et al., 2008). 
These observations seem to apply to the values for elastic modulus obtained in 
this study as they were considerably less than published values for fetal bone 
from cattle and deer in which somewhat different methodology was used (Currey 
and Pond, 1989; Garnero et al., 2006). The nature of fetal bone may have 
contributed to this discrepancy as plexiform bone is an orthotropic material, 
whose mechanical properties vary with the direction in which they are tested 
(Turner and Burr, 1993). 
Use of beam theory equations for calculation of stress and strain requires 
that many assumptions be made (Loveless, 1966; Westwater, 1949). Whilst 
these assumptions are commonly made but rarely satisfied completely in testing 
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bone, one must carefully consider the resultant error and determine whether it is 
of an acceptable level (Draper and Goodship, 2003). The results of this study 
suggest that the error from using classical beam equations is not acceptable 
when testing samples which vary in diameter, and confirm previous observations 
concerning comparisons of samples which vary in cortical thickness ratio (van 
Lenthe et al., 2008). It is unclear in these cases which assumptions for use of 
classical beam theory equations are invalid.  Some authors contend that the error 
is attributable to use of calculated values for strain rather than direct 
measurement of strain using strain gauges or extensometers (Turner and Burr, 
1993). The relationships between bone geometry and both ultimate stress and 
elastic modulus identified in this study suggest that neither calculation can be 
performed with an acceptable degree of error when comparing specimens 
differing in diameter, cortical thickness ratio or both.  
Even though the results of the present study did not demonstrate a 
statistically significant correlation between porosity and elastic modulus, it is 
unlikely that porosity is not a contributing factor given the well established 
relationship which has been determined in mature bovine cortical bone (Schaffler 
and Burr, 1988). Decreased porosity, as measured in the PI fetuses, included 
reduced average plexiform plate separation, which was only present in day 192 
fetuses. Our evaluation of determinants of biomechanical properties in fetal bone 
were by no means conclusive as other parameters such as the extent of Type I 
collagen cross-linking have been found to be important as well (Garnero et al., 
2006). 
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To our knowledge this study represents the first investigation of the effects 
of in utero viral infection on biomechanical properties of fetal bone and 
demonstration of the effect of reduced femoral mid-diaphyseal diameter on 
elastic modulus as calculated by classic beam theory. Although in utero infection 
with BVDV results in fetal femora with higher elastic modulus, the difference was 
largely accounted for by decreased periosteal appositional bone formation (Webb 
et al., 2012), and decreased mid-diaphyseal diameter rather than difference in 
the inherent biomechanical properties of PI fetal bone. Similarly, the decreased 
ultimate stress in day 245 fetuses was largely do to differences in bone 
geometry. The results of this study also suggest that inherent biomechanical 
properties of fetal cortical bone may exhibit a different relationship with important 


















DEVELOPMENT OF THE TYPE I INTERFERON RESPONSE IN FETUSES 
FOLLOWING IN UTERO INFECTION WITH BOVINE VIRAL DIARRHEA VIRUS 
 
Introduction 
 Infection with BVDV, a pestivirus in the family Flaviviridae, leads to 
significant economic losses for cattle producers worldwide (Moerman et al., 
1994; Valle et al., 2005). BVDV, small enveloped viruses with a single-stranded, 
positive-sense RNA genome of ~12.5 kb, are classified into two biotypes –
cytopathic (cp) and non-cytopathic  (ncp) - based on their lytic activity in cell 
culture (Gillespie, 1961). Both cp and ncp BVDV strains are able to cause acute 
infection in immunocompetent animals resulting in varying clinical manifestations 
ranging from mild subclinical disease to severe systemic disease and 
reproductive failure, including embryonic death, abortion and stillbirth (Brownlie 
et al., 1989; Murray, 1990). While both cp and ncp BVDV viruses are able to 
cross the placenta and infect the fetus, only ncp BVDV strains have the ability to 
cause persistent infection in fetuses infected during the first 150 days of 
gestation due to the insufficient development of the fetal immune system 
(Bielefeldt-Ohmann, 1995; Brownlie et al., 1989; Harding et al., 2002; McClurkin 
et al., 1984). Infection with BVDV in late gestation (after day 150) results in a 
transient infection that is cleared by the dam and fetus because adaptive immune 
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systems are sufficiently developed in both to mount an immune response to the 
infecting virus (Done et al., 1980; Goyal, 2005).  
 Ncp BVDV strains that are able to establish fetal persistent infection in 
early gestation provide excellent models for studying not only the feto-placental 
immune response to chronic viral infection, but also the effects of such infections 
on fetal development. We have shown previously that persistent infection 
adversely affects fetal growth (Smirnova et al., 2008) and development of 
multiple organs, including the brain (Bielefeldt-Ohmann et al., 2012; Bielefeldt-
Ohmann et al., 2008; Done et al., 1980) and bone (Webb et al., 2012). Persistent 
infection with BVDV also alters fetal antiviral immune responses (Hansen et al., 
2010; Shoemaker et al., 2009), and may alter maternal immune function through 
down regulation of CXCR4/CXCL12 and T cell receptor pathways in blood cells 
(Smirnova et al., 2009). Establishment of fetal persistent infection involves 
complex interactions between the maternal, fetal, and placental immune 
responses.  
 Cattle have an epitheliochorial placenta comprised of placentomes - the 
organs of nutrient exchange composed of a fetal and maternal component, the 
cotyledon and the caruncle, respectively (Bjorkman, 1957; Igwebuike, 2006)The 
microanatomic arrangement of epitheliochorial placentation precludes 
transplacental delivery of large maternal proteins such as immunoglobulins to the 
fetus (reviewed in (Chucri et al., 2010; Halliday, 1978).  The unique physiologic 
and anatomic characteristics of the ruminant placenta enables concurrent studies 
of the immune responses of the fetus, placenta, and dam in a way that allows 
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individual contributions as well as cause-effect relationships to be ascertained. 
Previously BVDV was shown to spread to and replicate in placenta of cows either 
acutely or persistently infected (PI) with BVDV (Fredriksen et al., 1999; 
Swasdipan et al., 2002). Binucleate trophoblast cells are one of the major 
reservoirs for the virus replication in placenta (Fredriksen et al., 1999) and are 
thought to play a role in the secondary spread of the virus from fetus to the dam 
(Swasdipan et al., 2002).  The complexity of the processes taking place at the 
maternal-fetal interface during establishment and maintenance of fetal persistent 
infection requires a thorough and comprehensive approach. 
 The first mechanism of antiviral defense is an innate immune response 
mediated by the induction of type I interferon (IFN), a family of proteins that 
includes, but is not limited to, IFN-, IFN-, and IFN-. IFN- plays an important 
role in maternal recognition of pregnancy in ruminants and is produced in large 
amounts during early gestation (reviewed in (Spencer and Bazer, 2004; Spencer, 
1996). Despite the ability of IFN- to upregulate IFN type I pathways, its role in 
the regulation of BVDV replication in placenta has not been studied extensively 
(Swasdipan et al., 2002). Likewise, there are no detailed studies in the literature 
pertaining to the production of IFN-α or IFN-β in virally infected bovine placenta.  
Virus must be recognized by host cells in order for an innate immune 
response to be induced. Toll-like receptors (TLRs) on the cellular membranes of 
immune cells along with RNA helicases in the cytosol serve as sensors for viral 
RNA (Kang et al., 2002; Yoneyama et al., 2004). Retinoic acid inducible gene I 
(RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are RNA 
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helicases, which are able to detect the presence of double stranded RNA 
(dsRNA) in the cell cytoplasm(Kato et al., 2006). These RNA helicases function 
as cytoplasmic pattern recognition receptors (PRRs), which detect the presence 
of pathogens by binding the pathogen-associated molecular patterns (PAMPs) 
within the cell and inducing the innate immune response through activation of the 
IFN type I cascade (Kato et al., 2006; Yoneyama et al., 2004). We have 
previously demonstrated robust up-regulation of both RIG-I and MDA5 in blood of 
pregnant heifers and fetuses transiently infected with ncp BVDV, while moderate 
up-regulation of RIG-I and MDA5 was also detected in PI fetuses at day 190 of 
gestation, 115 days post maternal infection (dpmi) with ncp BVDV and in PI 
yearling steers (Shoemaker et al., 2009; Smirnova et al., 2008). However, it is 
not known how early in gestation nor how soon after infection of the fetus with 
BVDV these PRRs can be activated.    
Induction of the type I IFN pathway leads to up-regulation of IFN 
stimulated genes (ISGs). Our previous study demonstrated up-regulation of 
multiple ISGs, including myxovirus resistance factor 2 (MX2), oligoadenylate 
synthetase 1 (OAS-1), and ISG15, in PI fetuses and steers (Shoemaker et al., 
2009). ISG15 is considered a prominent marker for the cascade of events 
induced by the type I IFNs in innate immune responses (Haas, 1987; Lenschow, 
2007), and for these reasons it has been chosen as a marker of ISGs up-
regulation in the present study. 
The current experiments were designed to delineate timing of the 
development of the innate immune response, in particular, the up-regulation of 
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PRRs, ISGs, and IFN- and IFN-, in fetuses and placenta during establishment 
of persistent infection with ncp BVDV. It was hypothesized that: i) chronic 
stimulation of innate immune responses occurs following viral infection of the 
fetus; ii) placental production of the type I IFN contributes to up-regulation of 
ISGs in PI fetuses. The presented data summarize our findings. 
 
 
Materials and methods 
 
Animals  
The Animal Care and Use Committee at Colorado State University 
approved all animal experiments using cattle. Forty-six weaned BVDV-naïve 
Hereford heifers were purchased from a source that did not vaccinate for BVDV 
and were transported to the Animal Reproduction and Biotechnology Laboratory 
at Colorado State University. Upon arrival all heifers were confirmed to be 
seronegative to BVDV1 and BVDV2 by using standard serum neutralization 
assay and BVDV-antigen-free in an ear-notch extracts-based BVDV antigen-
capture ELISA as described previously (Smirnova et al., 2008). Repeated serum 
neutralization assay for BVDV antibodies was performed one week prior to BVDV 
inoculation to confirm naïve status. 
At ~ 12 months of age estrous cycles of the heifers were synchronized 
and heifers were artificially inseminated with BVDV-free semen. Pregnancy was 






In vivo infection with BVDV and fetal collections 
 The experimental design is depicted in Figure 13. 
 
Figure 13. Experimental design. Estrous cycles were synchronized and heifers were 
artificially inseminated (AI) on day 0. Pregnant heifers were infected intranasally with ncp 
BVDV type 2 viral strain on day 75 of gestation to generate PI fetuses or kept BVDV-
naïve to generate control, uninfected fetuses. Fetal collections were performed through 
Cesarean section on days 82, 89, 97, 192, and 245 of gestation. 
 
 Prior to BVDV infection pregnant heifers were randomly assigned to two 
experimental groups - control and infected (n=23/group), which were kept 
separated in isolated pens. In order to generate PI fetuses, pregnant heifers of 
the infected group were inoculated with ncp BVDV2 strain 96B2222 (Van 
Campen et al., 2000) on day 75 of gestation. Each heifer received intranasal 
inoculation of a 2 ml aliquot of the virus stock aliquot 4.4 log10 TCID50/ml (PI 
group) as described previously (Smirnova et al., 2008) or a sham inoculation with 
2 ml of culture media (control group). Control heifers were kept away from the 
infected group and remained BVDV-free throughout the experiment. Blood 
samples for serology and RNA using Tri-reagent BD for blood derivatives 
(Sigma, USA) were collected from heifers on days 75, 78, 82, 85, 89, 97, 103, 
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115 during acute infection and seroconversion, and every two weeks thereafter, 
until day 245. Fetuses were collected by Cesarean section on days 82, 89, 97, 
192 and 245 (n=4 control/4 PI fetuses for day 82, 89 and 97; n=7 control/7 PI 
fetuses for the day 192; n=4 control/3 PI fetuses for the day 245 group). The 
latter group had only three PI fetuses due to the abortion of one fetus prior to the 
Cesarean section for reasons unrelated to the experimental infection. Fetal 
umbilical cord blood for RNA, serum and plasma, and fetal tissues for RNA and 
protein analysis were collected following Cesarean section and either preserved 
with Tri-reagent BD or snap-frozen in liquid nitrogen. Placentomes were collected 
at Cesarean section, and cotyledonary and caruncular parts were manually 
separated by gentle traction and snap-frozen in liquid nitrogen.  
 
Virus neutralization assay for BVDV antibodies  
 Serum of heifers was tested for presence of antibodies against BVDV1 and  
BVDV2 in bovine turbinate cells in 96-well plate format as described previously 
(Carbrey, 1973; Smirnova et al., 2008). Briefly, serum samples were 
complement- deactivated (30 min at 56° C) prior to 1 h incubation with cytopathic 
virus (Singer strain was used as BVDV type 1 and 125c as BVDV type 2) at 37° 
C and 5%CO2. After incubation bovine turbinate cells were added to each well, 
plates were incubated at 37° C and 5%CO2 for 3 days, and then examined for 
cytopathic effects of the test virus. Virus neutralizing titers for each serum sample 
were determined as the reciprocal of the highest dilution at which virus was 
completely neutralized. Titers lower than two were considered negative.   
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Analysis of gene expression by qRT-PCR  
 Detection of BVDV RNA was performed as previously described 
(Smirnova et al., 2008). Briefly, total RNA was extracted from samples of the 
umbilical cord blood preserved with Tri-reagent BD for blood derivatives (Sigma, 
USA) or from frozen caruncular and cotyledonary tissue using Trizol (Sigma, 
USA) according to manufacturer‘s protocols. Extracted RNA was purified using 
the RNeasy MinElute Cleanup kit (Qiagen, USA) and used for cDNA synthesis 
with the iScript cDNA synthesis kit (Bio-Rad, USA). Semi-quantitative real time 
PCR (qRT-PCR) was performed in a 384-well plate format on the LightCycler480 
(Roche, Basel, Switzerland) with IQ SYBR green Supermix (Bio-Rad, USA). 
Upon completion of qRT-PCR amplification melting curve analysis was 
performed to assess the quality of amplification; all amplicons were sequenced to 
confirm their match to the target genes. The qRT-PCR results were analyzed 
with the Comparative Ct (∆Ct) method and presented as 2
-∆Ct. Primers for BVDV 
were designed to target the conserved region of the 5‘UTR sequence, 
nucleotides 190-376. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA was used as an endogenous control for data normalization. All primer 
















GAPDH DQ403066 F: TGACCCCTTCATTGACCTTC 
  R: CGTTCTCTGCCTTGACTGTG 
BVDV GU395547.1 F: TCGTCAATGGTTCGACACTC 
  R: CCGCATGGGTTAAGATGTG 
ISG15 NM_174366 F:GGTATCCGAGCTGAAGCAGTT 
  R: CCTCCCTGCTGTCAAGGT 
RIG-I DQ471980 F: ACGTGCCAGAACAAATCAGA 
  R: TCTGGTTGAACCCTGACTGA 
MDA5 XM_615590 F: TGGGACTAACAGCTTCACCA 
  R: ACTGCATCAAGATTGGCACA 
IFN-α Z46508 F: TCTCTGTGCTCCATGAGGTG 
  R: TAGCTTGACCAGGAGGCTCT 
IFN-β M15477.1 F: GATGCCTGAGGAGATGAAGA 





 Statistical analysis of qRT-PCR data was performed using Student‘s t-test. 
Differences with the P < 0.05 were considered statistically significant. Data are 
presented as mean ± standard error (SE).  
 
Results 
Viremia in blood of fetuses and their dams  
 BVDV RNA in blood of infected heifers peaked on days 7 and 10 after 
BVDV inoculation (day 82 and day 85 of gestation, respectively) using qRT-PCR 
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(Fig. 14). Viral RNA was at a barely detectable concentration 14 dpmi with BVDV 
(day 89 of gestation), and was cleared from blood by 22 days after inoculation of 
the virus (day 97 of gestation). Seroconversion following BVDV infection of the 
heifers was confirmed at 28 dpmi (day 103 of gestation) using standard serum 
neutralization assay (data not shown). All control heifers remained free of virus 
throughout the experiment. 
 BVDV RNA was not detected in blood of PI fetuses collected on day 82 of 
gestation (7 dpmi with BVDV). Due to the difficulties in obtaining blood samples 
in early gestational fetuses, blood was collected only from one PI fetus on day 89 
of gestation. Viral RNA was detected in blood of this fetus, indicating that BVDV 
virus was able to reach the fetus by 14 dpmi. High concentrations of BVDV RNA 
were detected in all fetuses of the PI group collected on days 97 and 192, and in 
2 out of 3 fetuses collected on day 245 of gestation. One fetus from the day 245 
group had very low concentration of BVDV RNA, at the limit level of detection 
despite widespread virus antigen expression in tissues, detected by 
immunohistochemistry (Bielefeldt-Ohmann et al., 2012). The reason why this 
fetus has very little viral RNA within the blood is unknown. The greatest BVDV 
RNA concentration in fetal blood was detected on day 97 of gestation (22 dpmi 
with BVDV), with significant decrease in BVDV RNA by days 192 and 245 
(P<0.01; fold reduction between days 97 and 192 - 4.89, days97 and 245 - 13.1). 





 Figure 14. BVDV RNA in maternal and fetal blood (qRT-PCR). Peak of viremia in 
maternal blood was detected on days 82 and 85 of gestation. BVDV RNA was first 
detected in fetal blood 14 days after maternal BVDV inoculation (day 89 of gestation), 
and at all later time points (days 97, 192, and 245). Please note the difference in scale 
above and below horizontal line at y=1. Data are represented as mean  SE. 
 
Expression of type I IFN pathway in blood of pregnant heifers and their fetuses  
 Detection of ISG15 mRNA was used as an indicator of type I IFN pathway 
up-regulation in qRT-PCR performed on blood of fetuses and their dams. A 
robust 53.4-fold increase (P<0.001) in ISG15 mRNA concentration was present 
in whole blood of BVDV infected pregnant heifers 3 days post BVDV infection 
(day 78 of gestation), which significantly declined by 7 dpmi (day 82 of gestation; 
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P<0.001) and returned to baseline by 10 dpmi (day 85 of gestation; Fig. 15, A). 
ISG15 mRNA concentrations remained unchanged at the baseline level in blood 
of control heifers at all time points tested. No difference in ISG15 mRNA 
concentration was detected in blood of control and PI fetuses collected 7 dpmi 
(day 82 of gestation; Fig. 15, B). However, increase of ISG15 mRNA 
concentration was detected in blood of the PI fetuses collected at later time 
points - days 89, 97, and 192 (14, 22 and 117 dpmi, respectively), when 
compared to the control uninfected fetuses. While average ISG15 mRNA 
concentration in blood of PI fetuses on day 245 of gestation remained high, the 
difference was not statistically significant.  
 The concentrations of mRNA for cytosolic sensors – MDA5 and RIG-I - in 
fetal blood are shown in Fig. 15, C and Fig. 15, D, respectively. RIG-I mRNA 
concentration increased significantly in PI fetuses versus control fetuses as early 
day 82. RIG-I mRNA concentration in blood of PI fetuses increased gradually 
over the course of fetal infection and was significantly higher on day 97 
compared to day 82, and on day 192 when compared to day 97. Due to the high 
individual variation, the difference in RIG-I mRNA concentration between PI and 
control fetuses on day 245 was not significant, even though there was a trend for 
the average concentration in the PI group to be higher then in the control group 
(P=0.06). MDA5 mRNA concentration showed a possible tendency to increase in 
blood of day 89 PI fetus, was significantly higher in blood of day 97 PI fetuses  
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 Figure 15. Amplification of type I IFN pathway genes in fetal and maternal blood (qRT-
PCR). A, ISG15 mRNA in blood of pregnant heifers during acute stage of infection; B-F 
– fetal blood: B, ISG15 mRNA; C, MDA5 mRNA; D, RIG-I mRNA; E, IFN- mRNA; F, 
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IFN- mRNA. Data are represented as mean  SE. * - P<0.05, ** - P<0.01, *** - P< 
0.001. 
 
(P<0.001), and remained significantly higher in PI group compared to control 
group through days 192 and 245 of gestation. Both IFN- and IFN- mRNA were 
detected in very low concentrations in fetal blood, however, concentrations did 
not differ in PI compared to control fetuses (Fig. 15, E and F). 
 
Expression of IFNs and ISGs in caruncle and cotyledon 
 qRT-PCR was performed on caruncle and cotyledon tissues for BVDV 
RNA, IFN-, IFN-, and ISG15 mRNA on three selected time points representing 
the course of the establishing fetal persistent infection – days 89, 97, and 192 of 
gestation (Fig. 16). BVDV RNA was detected at similar concentrations in both 
cotyledon and caruncle tissue samples at each time point tested in PI group, 
while no viral RNA was amplified from cotyledons and caruncles of the control 
group (data not shown). No differences were found for IFN- and IFN- mRNA 
concentrations in caruncle between the control and PI groups on any of the days 
of gestation tested (Fig. 16, A and C). However, significant increase in ISG15 
mRNA concentration was found in caruncles of the PI vs. control group (Fig. 16, 
E) on days 97 and 192 (2.6-fold and 4.13-fold, respectively).  
 No differences in IFN-, IFN-, and ISG15 mRNA concentrations were 
detected in cotyledons on days 89 and 97 of gestation when PI fetuses were 
compared to controls (Fig. 16, B, D and F, respectively). However, mRNA  
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 Figure 16. Amplification of IFN-, IFN-, and ISG15 mRNA in caruncle and cotyledon 
(qRT-PCR). A significant increase in IFN-, IFN-, and ISG15 mRNA was detected in 
cotyledons of the PI fetuses on day 192 of gestation. Only ISG15 mRNA concentrations 
increased on days 97 and 192 in caruncle. Caruncle: A, IFN- mRNA; C, IFN- mRNA; 
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E, ISG15 mRNA. Cotyledon: B, IFN- mRNA; D, IFN- mRNA; F, ISG15 mRNA. Data 
are represented as mean  SE. * - P<0.05, ** - P<0.01. 
 
concentrations for all three genes were significantly higher on day 192 in PI 
compared to the control group: 9.3-fold for IFN- mRNA, 3.0-fold for IFN- 
mRNA, and 2.9-fold for ISG15 mRNA (P<0.05).  
 
Discussion 
 Studies of transplacental viral infections present challenges due to the 
complexity of the processes occurring during the establishment of infection and 
the contribution of multiple factors of maternal and feto-placental immune 
responses affecting viral spread and replication. In order for the virus to 
successfully infect the fetus it has to replicate in maternal blood and tissues, 
reach and cross the placenta before maternal immune response clears the virus 
in the dam. The time course required to establish sufficient maternal infection 
and to spread to the fetal blood likely accounts for the delay in fetal viremia. In 
the experimental model described herein, maternal viremia was detected 7 days 
after BVDV inoculation, reproducing findings of a related previous study 
(Smirnova et al., 2008). Fetuses, collected at the peak of maternal viremia (7 
dpmi) did not have any detectable BVDV RNA or antigen. BVDV RNA in fetal 
blood was detected later, namely, 14 days after BVDV inoculation of their dams, 
at the time when virus was almost cleared from the maternal blood circulation. 
Detection of BVDV RNA in fetal blood coincides with the first detection of BVDV 
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antigen in the brain of two fetuses collected at 14 dpmi as described in a 
previous publication (Bielefeldt-Ohmann et al., 2012). This finding indicates that 
fetal viremia and subsequent viral dissemination to the brain of infected fetuses 
occur between 7 and 14 dpmi. Other studies have described a 72-hour interval 
for the spread of the virus to fetal tissues(Swasdipan et al., 2002; Tsuboi et al., 
2011). The time needed for the virus to reach the ruminant fetus can depend on 
the species, virulence of the virus isolate, stage of gestation at the time of 
infection, infectious viral dose, and route of infection. The study, described by 
Swasdipan et al. (2002), was performed with a sheep model using intranasal 
inoculation, while the study of Tsuboi et al. (2011) used intravenous inoculation in 
cows. Both studies used different virus isolates than herein and maternal 
challenge took place in the first month of the gestation: much earlier than in our 
model.  
In the present experiment BVDV was cleared from maternal blood by 22 
dpmi with BVDV, which coincided with the peak of BVDV RNA concentration in 
the fetal blood. Comparison of the BVDV RNA concentrations in maternal and 
fetal blood at the peaks of viremia (day 82 and day 97, respectively) revealed 
striking, ~30,000-fold increase in fetuses compared to dams. The difference in 
the competence of the immune system between adults and their fetuses in early 
gestation, as well as the ability of BVDV to replicate more efficiently in fetal cells, 
might explain the much higher levels of BVDV in fetal blood. Inability of the fetus 
at early gestation to develop an adequate adaptive immune response is thought 
to be the key factor allowing the development of fetal persistent infection 
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(Peterhans et al., 2003; Potgieter, 1995). Surprisingly, BVDV RNA 
concentrations decreased significantly between day 97 and day 192 (~5-fold) and 
day 245 (~13-fold) collected fetuses. As noted in the Results, one of the three 
day 245 PI fetuses had barely detectable BVDV RNA concentration, although 
viral antigen was detected in the brain (Bielefeldt-Ohmann et al., 2012) and liver 
(Morarie S. E., unpublished data) of this fetus. 
We have previously demonstrated a transient robust increase of ISG15 
mRNA concentration in blood of pregnant heifers infected with the same strain of 
ncp BVDV as early as 3 dpmi (Smirnova et al., 2008), which is prior to the 
establishment of detectable viremia. The same drastic, but short-term (3-7 dpmi), 
ISG15 up-regulation was detected in blood of infected heifers in the current 
experiment. In contrast, the increase in ISG15 mRNA concentration in fetal blood 
coincided with fetal viremia, 14 days after maternal inoculation with BVDV. ISG15 
mRNA concentration remained increased for almost the whole duration of 
experiment (until at least day 192), indicating that the factor responsible for the 
induction of ISGs persists in the PI fetuses. Increased expression of ISG15 
mRNA was also detected in fetal spleen and bone marrow (data not shown), and 
ISG15 protein up-regulation was found in fetal brains with immunohistochemistry 
starting at 14 dpmi (Bielefeldt-Ohmann et al., 2012). 
The ability of ncp BVDV viruses to evade the innate immune response and 
failure to induce type I IFN pathway through inhibition of IFN regulatory factors 3 
and 7 has been described (Baigent et al., 2004; Baigent et al., 2002; Schweizer 
et al., 2006). However, the ncp BVDV strain used in our experiments induces 
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strong antiviral activity in blood of infected animals and robust up-regulation of 
ISGs in blood and tissues (Bielefeldt-Ohmann et al., 2012; Shoemaker et al., 
2009; Smirnova et al., 2008). The rapidly developing chronic up-regulation of 
ISGs in the PI fetuses in our model demonstrates an ability to provide at least 
partial control over viral replication in the PI fetuses, leading to the decreased 
viremia in fetuses later in infection/gestation. One fetus, collected at day 245, 
with very low levels of BVDV RNA in the blood, also had concentrations of 
ISG15, RIG-I, and MDA5 mRNA, comparable with concentrations in blood from 
control uninfected fetuses. 
The innate immune response is triggered by the recognition of pathogen-
associated molecular patterns such as viral dsRNA (Saito and Gale, 2007). RNA 
helicases RIG-I and MDA5 serve as pattern recognition receptors responsible for 
detection of pathogen‘s nucleic acids and induction of the type I IFN cascade 
(Kang et al., 2002; Yoneyama et al., 2004). RIG-I, shown to play a key role in 
recognition of RNA viruses, specifically and preferentially associates with the 
copy-back defective interfering RNA particles produced during viral replication 
(Baum and Garcia-Sastre, 2011). Very rapid increase of RIG-I mRNA 
concentration in PI fetuses might indicate that not only RIG-I is present in early 
gestation, but also is able to detect very low number of viral particles and trigger 
the type I IFN pathway, precluding fetal viremia. This is the first report 
demonstrating that RNA helicases RIG-I and MDA5 can be induced in bovine 
fetuses as early as the first trimester, thus contributing to the induction of the 
innate immune response to BVDV infection.  
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Despite significant up-regulation of RIG-I, MDA5, and ISG15 in fetal blood 
and other tissues, there was no difference in the mRNA concentrations of IFN- 
or IFN- in blood of PI fetuses and control uninfected fetuses at any time point 
examined. IFN- and IFN- mRNAs were also present in fetal spleen and bone 
marrow, but their concentration did not differ when compared to healthy control 
fetuses (data not shown). We have previously demonstrated low antiviral activity 
in blood of only 1 out of 6 PI fetuses in the previous study (Smirnova et al., 
2008). Two questions surface based on the findings: what is causing up-
regulation of ISGs in fetuses during the establishment of PI and which tissues 
produce these ISGs? 
High antiviral activity was detected previously in the blood of pregnant 
heifers 7 dpmi with ncp BVDV (Smirnova et al., 2008). The type I IFNs found in 
the maternal blood during the acute phase of maternal infection could potentially 
induce ISGs in the fetuses collected during the first 2 weeks after maternal BVDV 
inoculation if IFNs are able to cross the bovine placenta. We have shown that in 
vitro treatment of naïve peripheral blood mononuclear cells (PBMC) with uterine 
vein serum collected at day 82 surgeries (7 dpmi) is able to upregulate RIG-I and 
ISG15 mRNAs (Weiner et al., 2012). Uterine vein serum collected 3 weeks after 
maternal infection (following seroconversion) was not able to cause up-regulation 
of ISGs in naïve PBMC. To our knowledge there is no clear information in the 
literature that proves the ability of IFNs or lack thereof to cross the bovine 
placenta. Thus the mechanism leading to the induction of fetal ISGs in 
establishing persistent infection remains unanswered. 
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Another potential source of IFNs is the placenta itself. It has been shown 
that trophoblast cells in human placenta are able to produce type I IFNs when 
stimulated by Sendai virus infection (Aboagye-Mathiesen et al., 1991). High 
levels of IFN- in placenta during pregnancy are thought to protect the fetus from 
intrauterine herpes simplex virus infection (Zdravkovic et al., 1997). To evaluate 
the possibility of placental IFN production we analyzed both IFN- and IFN- 
mRNA concentration in caruncles and cotyledons on days 97, 192, and 245 of 
gestation. Both IFN- and IFN- mRNAs were present in low concentration in 
bovine placenta of BVDV naïve heifers, (caruncular (maternal) and cotyledonary 
(fetal) tissues). While BVDV RNA was present and ISG15 mRNA was 
upregulated in caruncles and cotyledons of the placentome, only cotyledons had 
higher concentrations of IFN- and IFN- mRNA in fetuses during the 
established fetal PI (117 dpmi). These data combined with the absence of IFN- 
and IFN- mRNA up-regulation in fetal blood, bone marrow and spleen suggest 
that at least during later gestation the cotyledon might be a source of the type I 
IFN production contributing to the chronic up-regulation of ISGs in PI fetuses. 
While cotyledon might be the source of the type I IFN secretion, which leads to 
up-regulation of ISGs in the fetal tissues, it does not explain why fetal cells 
appear incapable of up-regulating type I IFN expression in response to BVDV, 
when virus is present both in the placenta and fetus. Additional studies focused 
on elucidating potential reasons for the phenomenon are needed. 
The presented data provide novel insights into the intriguing complex 
phenomenon of establishment of transplacental persistent infection with BVDV. 
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Significant questions such as, why fetal tissues are unable to produce the type I 
IFNs in response to BVDV infection in contrast to placenta, have arisen from this 
study. Further studies are therefore required to elucidate the complex 
interactions between the virus and maternal and feto-placental immune 
responses. 
 In summary, it is concluded that fetuses respond to the early gestational 
ncp BVDV infection with the induction of the type I IFN pathway, resulting in 
chronic ISGs up-regulation. The placenta, more specifically, the cotyledon, might 
be responsible for the production of IFNs and thus up-regulation of fetal ISGs. 
The innate immune response of the fetus may be partially effective in curtailing 
viral replication, but is not able to eliminate the virus without contribution from the 


















 These studies investigated the morphogenesis of fetal skeletal lesions, 
biomechanical effects of PI on the developing skeleton and temporal 
development of the innate immune responses to PI.  The experimental model 
utilized for this work was unique in that fetuses were collected at multiple time 
points both within the acute and chronic stages of PI.  
 The major findings that emerged from examining the morphogenesis of 
fetal skeletal lesions were the cyclic nature (approximately 15 days) of the growth 
retardation lattices, which arise secondary to decreased osteoclast numbers, and 
impaired tissue level bone formation. Radiographically apparent skeletal lesions 
were not documented until day 192 of gestation (117 days post maternal 
inoculation), although there were tendencies for both trabecular bone volume to 
be increased and osteoclast numbers to be decreased on day 97 of gestation (22 
days post maternal inoculation). Fetal viremia peaks some time between days 97 
and 192, most likely closer to day 97, which coincides with the initial lesions in 
some day 97 fetuses. With increasing fetal age, bone lesion severity increases, 
while the level of viremia decreases.  This observation along with the absence of 
viral antigen or cytopathic lesions within osteoclasts suggests that BVDV does 
not directly affect osteoclasts.  
 The reduced tissue level bone formation was an unexpected finding that 
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could result from impaired osteoblast differentiation, proliferation, activation or 
recruitment.  In states of reduced bone resorption, such as in PI fetus, impaired 
bone formation appears to be common due to the extensive cross-talk and 
regulatory control by osteoclasts and osteoblasts over one another (Martin and 
Sims, 2005).  C-fos deficient mice, which develop severe osteopetrosis 
secondary to impaired osteoclast differentiation have impaired bone formation 
rates (Grigoriadis et al., 1994). C-fos and its osteoclast specific transcriptional 
target, fos like antigen 1, are downregulated in the bone marrow of PI fetuses 
and may indicate that osteoclast differentiation is impaired (APPENDIX IV). 
Attempts to determine whether a soluble factor within the serum, such as IFN-I, 
was present and capable of impairing osteoclast differentiation in vitro were 
fraught with high inter/intra assay variations but revealed no major differences. 
The cause of reduced osteoclast numbers was not definitively identified. The 
cause of the cyclic nature of the metaphyseal lesions was not extensively 
investigated although a cyclic impairment of osteoclast differentiation seems 
most probably based on the collective data.  Serial collection of bone marrow or 
fetal blood samples during the time course of lesion development may lend 
additional information with respect to effects on other cell types and potential 
mechanisms underlying this unique feature. 
 Congenital BVDV infections has been associated with neonatal longbone 
fractures (reviewed in CHAPTER III), however mechanical testing of fetal femora 
on day 192 and 245 did not reveal any significant reduction in bone material 
properties, nor composition.  An unexpected finding of the mechanical testing 
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experiment was the marked effect of cortical geometry on area normalized 
mechanical parameters.  Mechanical testing of beams machined from cortical 
bone would have alleviated any effect of cortical geometry and been a better 
experimental approach to determine whether inherent biomechanical properties 
of long bones were compromised by PI.  The mild nature of bone lesions 
obtained may have been an important contributor to the lack of observed 
biomechanical effects as the lesions were less severe than those obtained during 
previous infections with the same viral strain and dose (Smirnova et al., 2008).  
The reason for the latter is not clear but presumably is related to differences in 
host or environmental factors.  
 Examination of the temporal development of the innate immune response 
not only revealed interesting findings, but also gave rise to additional questions. 
Upregulation of IFN- and IFN- mRNA concentrations in the cotyledon of PI 
fetus in the absence of detectable upregulation of these genes in fetal tissues 
was the most significant finding.  This finding lead to the question of why PI 
fetuses are unable to upregulate IFN- and IFN- when they are: 1) 
physiologically able to produce IFN-I and 2) respond to type I IFN with massive 
upregulation of ISGs in all tissues evaluated.  There are approximately a dozen 
manuscripts describing inhibition of type I IFN production by BVDV nonstructural 
proteins (reviewed in CHAPTER IV), but this virus-interferon regulatory factor 
interaction does not fully explain the discrepancy between type I IFN production 
in the two tissues knowing that virus is present in both locations (fetal tissues, 
cotyledon).   It seems plausible that the epigenetic dysregulation documented in 
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PI fetuses (APPENDIX) may have a role in silencing fetal type I IFN production 
,but not placental type I IFN production as there are marked differences in 
epigenetic regulation of gene expression between the fetus and placenta 
(Chapman, 1984; Rossant, 1986). Expression of IFN- and IFN- genes do not 
appear to be regulated by methylation of DNA cytosine residues as the promotor 
regions of these genes lack classical CpG islands.  This observation certainly 
does not discount the possible effect of other epigenetic mechanisms (reviewed 
in APPENDIX VI) exerting control on type I IFN gene expression nor the effects 
of such mechanisms on other genes that regulate type I IFN expression. 
Although the experimental model that was used for these experiments enables 
one to investigate the temporal aspects of PI by collecting fetuses during different 
time point during the course of infection, its single limitation is the low numbers of 
animals at each collection points compounded with marked individual variation in 
fetal response to PI manifesting as variation in lesion severity. The individual 
variations in fetal response to PI continues to be a source of intrigue and 
underscores not only the complexity of the model used but also how little we 
know about the effects of fetal, placental and maternal (host) factors on the 
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 A previous experimental infection documented generalized growth 
restriction in day 190 fetuses PI with BVDV (Smirnova et al., 2008).  To this end, 
fetal size, weight, select organ weight and long bone size were measured at each 
collection time to determine the temporal nature and scope of growth and 
developmental impairment in PI fetuses.  
 
Materials and Methods 
 On each day of collection (Days of gestation 82, 89, 97, 192, 245) crown-
rump length, heart girth, body weight, liver weight, adrenal and 
thyroid/parathyroid weight were determined.  Ponderal Index as calculated using 
the following formula: Weight/Crown-Rump length3) x 100 (Rohrer, 1921).   
Skeletal growth parameters are presented in Table 2 (CHAPTER II), Table 5 
(CHAPTER III), and Table 10 (APPENDIX II) 
 
Results 
 There were no differences between PI and Control fetal growth 




Discussion   
 PI fetuses in this study were not growth restricted nor did they have 
impaired organ development that manifest as altered organ weights.  The reason 
why PI did not lead to growth restriction similar to the previous study (Smirnova 
et al., 2008) is unclear.  PI fetuses may have been more mildly affected than 
those of the previous as marked of femoral cortical thickening, which was 
identified in PI fetuses in the previous study (Smirnova et al., 2008), was not 
seen in all PI fetuses studied herein.  Other potential confounding factors include 
unequal sex distribution between PI and Control groups. The use of sexed 
semen in future experiments may be of benefit in eliminating the effect of sex. 
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Table 9. General growth parameters of PI and Control fetuses (Mean  standard deviation) 
Gestational 
age (days) 









82 Control 4/Male 14.8  0.7 10.7  0.5 0.12  0.01 3.86  0.46 
82 PI 3/Male, 1/Female 14.6  0.5 10.1  0.2 0.11  0.01 3.58  0.55 
89 Control 4/Male 17.3  0.5 12.2  0.4 0.19  0.02 3.70  0.18 
89 PI 2/Male, 1/Female 15.8  0.4 11.7  0.5 0.17  0.02 4.22  0.20 
97 Control 4/Female 20.3  0.7 14.0  0.7 0.30  0.03 3.57  0.21 
97 PI 3/Male, 1/Female 21.3  1.0 14.6  0.9 0.34  0.06 3.51  0.24 
192 Control 3/Male, 4/Female 64.6  3.5 44.4  1.5 9.04  0.76 3.39  0.55 
192 PI 2/Male, 5/Female 63.8  1.7 42.8  1.9 8.15  0.99 3.13  0.24 
245 Control 2/Male, 2/Female 90.3  1.0 63.5  1.3 25.34  0.40 3.45  0.16 
245 PI 3/Male 89.7  2.3 61.7  1.2 24.83  1.80 3.47  0.54 
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Table 9. cont. 
Gestational age 
(days) 
Infection status Liver weight (g) Adrenal weight (mg) Thyroid/Parathyroid 
weight (mg) 
82 Control 4.37  1.58 77  3 71  2 
82 PI 4.07  0.15 72  2 70  3 
89 Control 8.23  1.48 95  17 80  12 
89 PI 7.27  0.82 104  14 81  16 
97 Control 11.10  1.12 124  43 129  23 
97 PI 13.99  1.59 139  9 158  19 
192 Control 267.14  44.24 1131 295 3470  498 
192 PI 260.71  57.33 988  260 3570  426 
245 Control 542.50  15.00 2296  380 8997  2103 
245 PI 533.34  57.74 2099  242 8559  1915 
 







 Impaired bone resorption would most severely affect those individual 
bones having the highest rates of growth or most extensive osseous drift.  Rib 
growth occurs by both endochondral ossification and intramembranous 
ossification.  Endochondral ossification is responsible for the majority of 
longitudinal growth, which primarily occurs in the physis at the costochondral 
junction.  The bone that is formed by this process is woven bone, which is 
deposited on calcified cartilage cores (primary bone).  During rib growth, in order 
to accommodate the growth of thoracic cavity organs and outward drift, primary 
bone must be resorbed on the periosteal surface of the medial cortex and the 
endocortical surface of the lateral cortex. Meanwhile bone formed by 
intramembranous ossification, is deposited on the endocortical surface of the 
medial cortex and the periosteal surface of the lateral cortex. Due to impaired 
bone resorption secondary to reduced osteoclast numbers (Webb et al., 2012) in 
PI fetuses it was hypothesized that ribs from PI fetuses would have greater 
proportions of primary bone as well as cartilage core volumes and these 
proportion may differ between the medial and lateral cortices if osseous drift was 
significantly affected.  
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Material and Methods 
 Ribs from Day 192 fetuses were selected based on the increased number 
of fetuses and the greater severity of metaphyseal lesion than other collection 
days. The entire right 8th rib was collected at fetal necropsy and measured from 
the head to the costochondral junction (straight line).  Based on these 
measurements, precise mid-rib cross-sections were cut with a band saw and 
decalcified as previously described (Webb et al., 2012).  Medial and lateral 
cortical thicknesses (width, mm), medial and lateral bone volume (BV/TV, %), 
bone volume of original woven bone (primary bone) (1 BV, %), and cartilage 
core volume (Cg.V/BV, %) were determined. 
 
Results  
 The results of the morphometry appear in Table 10.  Both the medial and 
lateral rib cortices from PI fetuses had higher Cg.V than Controls.  All other 
parameters assessed did not differ between Control and PI fetuses although 




 Collectively, increased Cg.V in the face of similar1 BV suggests that PI 
with BVDV primarily affected rib growth through impaired modeling of primary 
spongiosa during initial endochondral ossification rather than affecting the 
modeling during osseous drift in which case 1 BV would be expected to be 
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Medial Cortex Lateral Cortex 
  Width 
(mm) 
BV (%) Cg.V (%) 1BV (%) Width 
(mm) 
BV (%) Cg.V (%) 1 BV 
(%) 




94.9    
1.3 
1.45    
0.5 




87.7    
8.4 
0.3      
0.3 
15.4    
3.6  




91.2    
4.2 
2.6      
0.7b 




84.6    
5.0 
3.9      
1.6b 
17.5    
3.7 
a Tendency for difference from Control (P < 0.07) 
b Difference from Control (P < 0.5)
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increased.  The most likely reason why osseous drift was not affected in the PI 
fetuses might be impaired bone formation, which was documented in both the 
tibia and femur (CHAPTER II).  Thus, when bone formation and resorptive 
processes are both impaired proportionately no net changes in bone composition 


























 This experiment was performed to test the hypothesis that PI with BVDV 
results in decreased numbers of CD14 positive cells (osteoclast-macrophage 
precursors) within the bone marrow. 
 
Materials and Methods 
  Bone marrow cells were isolated from the marrow cavity of fetal long 
bones by flushing with -MEM media to dislodge the cells.  Cell viability was 
assessed prior to immunostaining with trypan blue. The cells were then strained 
to remove any bone spicules and other tissue debris. Red blood cells were lysed 
with a solution of NH4Cl (0.15M), KHCO3 (10mM), Na2EDTA (0.1mM) and cells 
were removed by centrifugation at 1,200rmp for 10 minutes.  The cells were then 
incubated with antibody for 30 minutes at room temperature followed by rinsing 
twice with phosphate buffered saline (pH 7.4).  Cells were analyzed on a CyAn 






Table 11. Antibodies used for bone marrow flow cytometry. 

















B cells 1424F 1:100 
Anti-CD45- APC 
conjugated 






a All antibodies from ABD-serotec, Raleigh, NC. 
 
Results 
 The results of flow cytometry staining appear in Table 12.  Overall a small 
percentage of cells stained double positive for the cell markers used.  There were 
significantly reduced numbers of CD4+/CD45– cells in PI bone marrow when 
compared to controls.  There were no differences in the percentage of other cell 
populations between PI and Control animals.
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Table 12.  Flow cytometry of bone marrow from day 192 PI and Control fetuses. (Mean  standard deviation) 
Infection Status Percent of Histogram 
 CD4+/CD45+ CD8+/CD45+ CD14+/CD45+ CD21+/CD45+ WC-1+/CD45+ 
Control 0.70  0.39 0.68  0.41 0.84  0.83 0.43  0.16 0.54  0.42 
PI 0.78  0.38  0.77  0.39 0.81  0.64 0.44  0.41 0.35  0.18 
 Percent of Histogram 
 CD4+/CD45- CD8+/CD45- CD14+/CD45- CD21+/CD45- WC-1+/CD45- 
Control 49.5  4.8 47.7  8.0 12.3  2.7 14.3  13.7 1.8  1.3 
PI 35.3  5.8a 31.8  5.2 9.7  2.6 6.6  6.5 4.7  5.3 
a Difference from Control (P < 0.05)
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Discussion 
 Two significant limitations of this experiment include the low number of 
viable cells at the time of cytometry and the small percentage of cells that stained 
positively for the markers. The results did not support the hypothesis that 
CD14+/CD45+ cells would be present at lower numbers in the PI bone marrow.  
It is however difficult to draw definitive conclusion on this finding because the 
percentage of cells is so low and near the limit of detection of this assay.  The 
considerable percentage of CD4+/CD45– cells, which were decreased in PI bone 
marrow, likely reflect staining of erythroid precursor cells as they have been 
shown to have this immunophenotype in human bone marrow (Cleveland and 
Liu, 1996).  This may suggest that erythropoeisis is impaired in PI fetuses.  The 
concurrent high numbers of CD8+/CD45- cells is assumed to be associated with 














IN VITRO OSTEOCLAST ASSAYS 
 
Introduction 
 Osteoclast numbers tended to be reduced in day 97 PI fetal tibia and were 
reduced in day 192 PI fetal tibia which lead to abnormal trabecular modeling as 
previously described in Chapter II (Webb et al., 2012).  The absence of histologic 
features of necrosis or apoptosis within mature osteoclasts of days 82, 89, 97 
and 192 fetuses suggests that osteoclast proliferation and/or differentiation may 
be affected by PI. However, minor alteration in osteoclast function or survival 
could significantly affect overall osteoclastic resorption, especially in states of 
decreased osteoclast density as described above. Reduced numbers of 
osteoclasts could potentially result from either impaired proliferation of precursor 
cells or impaired differentiation of precursor cells into mature osteoclast. This 
series of experiments was conducted to assess osteoclast differentiation and 
resorptive functions in PI fetuses and test the hypothesis that there is a soluble 
factor, present in PI fetal serum, which impairs osteoclast precursor proliferation 
or differentiation.  Functional assays were also performed to assess for functional 





Materials and Methods  
Experiment I 
 Bone marrow cells were collected by the following procedures:  The 
marrow cavity of fetal long bones was flushed with -MEM media to dislodge 
cells.  The cells were then strained to remove bone spicules and other tissue 
debris.  The cells were counted, viability determined by trypan blue staining, and 
frozen in -MEM media with 20% FBS and 20% DMSO as previously described 
(Mengeling, 1988). The cells were thawed quickly in -MEM media with 15% 
glycerol which has been shown to be optimal for thawing bone marrow cells 
(Tran, 1960). PI and Control fetal bone marrow cells were cultured at 4 x 105 
cells/well in 24 well plates in Phenol-free -MEM media with 10% FBS 
(harvested from either PI or control fetuses, virus-free) and 2 mM L-glutamine for 
24, 48, and 72 hours. 
 
Experiment II 
 Differentiation Assay 
 Peripheral blood mononuclear cells (PBMC) from a yearling angus bull 
calf were isolated as previously described (Weiner et al., 2012).  In summary this 
method uses Histopaque 1077® (Sigma Aldrich, St Luis, MO) solution to 
separate PMBC from red blood cells and granulocytes based on cellular density.  
The isolated PBMC were counted and viability determined. Cells were plated on 
200m thick dentine discs in 24 well plates (5 x 105 cells/well containing Phenol-
free -MEM media with 10% FBS, harvested from either PI or control fetuses 
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(virus-free), 25 mM Hepes, 1% solution of penicillin, gentamicin and 
Amphotericin B and 35 nM of recombinant human receptor activator for nuclear 
Kappa B ligand (RANKL) and 50 nM of recombinant human macrophage colony 
stimulating factor (M-CSF).   Fetal serum was heat inactivated at 56 degrees 
Celsius for 30 minutes. All media was sterilized by filtration (0.2 m pore size). 
The dentine discs were produced by embedding bovine incisors in an epoxy 
resin (Sample- Kwick®, Beuhler, Ltd Lake Bluff, IL, USA) and cutting cross 
section on an diamond blade saw (Isomet saw®, Beuhler, Ltd Lake Bluff, IL, 
USA) followed by hand grinding to 100 m thickness.  The discs were sterilized 
in 70% ethanol. After two hours of culture non-adherent cells (lymphocytes) were 
removed and media was replaced.  Media was replaced every three days 
thereafter.  Cultures were terminated at day 0 (2 hours after initial plating), day 4, 
and day 8 at which time the media was removed and discs were fixed with citrate 
buffered acetone and stained with a commercial enzyme histochemical kit for 
Tartrate-resistant Acid Phosphatase (TRAP) (Sigma Aldrich, St Luis, MO). 
 
Pit resorption assay 
  TRAP staining discs were sonicated for 30 seconds in DI water and 
stained with a 0.1% aqueous solution of toluidine blue with sodium borate for 30 







 The viability of previously frozen bone marrow cells was poor (less than 




 Representative photomicrographs of TRAP stained dentine discs are 
presented in Figure 17.  TRAP positive osteoclast-like cells were first observed 
after 3 days of culture.  Extending the culture length out to 14 days did not result 
in significant increases in TRAP positive osteoclast-like cell numbers, rather after 
day 8 of culture osteoclast-like cells increased in size and gained additional 
nuclei (Qualitative evaluation).   There was no discernible difference between 
cultures treated with PI serum versus Control serum and a high degree of 
intra/inter-assay variation was noticed.  
 
Conclusions  
 The most significant pitfall in this assay was the extreme intra-assay 
variation in the number of TRAP positive osteoclasts-like cell numbers such that 
meaningful data resultant from quantitating these cells could not be produced.  A 
potential reason for this may be related to the scarcity of permissible cells in 
peripheral blood. While the percentage of PBMC capable of efficiently 
differentiating into osteoclasts in cattle are unknown such cells are exceedingly 
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rare (< 0.01%) in peripheral blood of humans (Ritchlin et al., 2003) and even 
when plating 500,000 cells per well the exact number of precursor cells was 
unknown.   This type of variation appears to be a common problem when using 
PBMC rather than selectively enriched cell populations, such as CD14+ cells, for 
differentiation assays (Nicholson, 2000).  Utilizing fluorescent antibody cell 
sorting to produce an enriched population of osteoclast precursors would likely 
lend more consistent results.  Although the pit resorption assay was standardized 
in this series of experiments it was not completed due to the poor results 




Figure 17.  Photomicrographs of dentine discs stained for TRAP from days 0, 4, and 8 
osteoclast-like cell cultures. Numerous TRAP positive osteoclast-like cells can be seen 
(pinpoint red dots) on the surface of both Control (C and E) and PI (D and F) discs. 
Osteoclast-like cells are noticeably larger in cultures from day 8 (E and F). Disc A and B 























FETAL BONE MARROW GENE EXPRESSION 
 
Introduction  
 The mRNA expression of molecular mediators of osteoclast differentiation 
were evaluated by qRT-PCR in bone marrow.  mRNA expression of 
receptor/ligands, intermediate mediators in signal transduction pathways and the 
transcriptional targets of such pathways were evaluated. It was hypothesized that 
if osteoclast differentiation was impaired in PI fetuses there would be down 
regulation of mRNA transcripts of either receptor/ligands, transcription factors 
activated by these pathways, transcriptional targets of these pathways or up 
regulation of negative regulators (inhibitors).  
 
Materials and Methods 
 Spicules of distal femur metaphyseal bone marrow were obtained at fetal 
necropsy, placed in Tri-Reagent (Sigma Aldrich, St Louis, MO), and snap frozen 
in liquid nitrogen until analysis.  Total bone marrow mRNA was isolated with Tri-
Reagent and purified with RNeasy MinElute Cleanup Kit (Quiagen, Valencia, CA) 
as previously described (Smirnova et al., 2008). Target genes and corresponding 
primer sequences appear in Table 13. Primer sequences for GAPDH, RIG-I, 




Table 13. qRT-PCR primer sequences 
Target Gene Accession number Primer sequence 
Calcitonin 
Receptor 




NM_001205770.1 F: GCTCCATGAAAACACGGATT 
R: CTGCACAGCTGCTTGAAAAG 








XM_002697844.1 F: GCTGCTCTTCATGTCTGTGG 
R: ACCCAGTGCCACAAATTAGC 
IL-1R1 NM_001206735 F: GCTGAAGTGGAGGATTCAGG 
R: TAGGCTCATGCTGCACAAAC 
IL-1R2 NM_001046210.1 F: CATGACGTATGCCCACAAAG 
R: GGGGAGAGATGATCACAGGA 
MITF NM_001001150.1 F: TGAGTCGGATCATCAAGCAG 
R: TGTGAGATCCAGGGTTGTTG 
NFAT1c NM_001166615.1 F: CTTTCTGCAGGACTCCAAGG 
R: TCGGCTTACACAGGTCTCCT 
c-fos AY322482.1 F: CGTCTTCCTTCGTCTTCACC 
R: AGTCAGAGGAAGGCTCGTTG 
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TRAF6 NM_001034661.1 F: AGATTGGCAACTTTGGGATG 
R: ACAGGTTGTAGCCGGGTTTG 
IL-1 NM_174092.1 F: GGATTCTCCAGGCAAGAACA 
R: GAGTCGGACATGACTGAGCA 
IL-1 NM_174093.1 F: CAGTGCCTACGCACATGTCT 
R: GGAGGACGTTTCGAAGATGA 
CSF-1 NM_174026.1 F: AGAGCTTTGAGTCGCCAGAG 
R: ACGTCTTCCATCCCAGTGAC 




NM_001098056.1 F: AACTGGCTCAGTGTCCTGGT 
R: CTCGTGAGTTGTGTCGCTGT 
CXCR4 NM_174301.2 F: AAGGCTCAGAAGCGCAAG  
R: GAGTCGATGCTGATCCCAAT 





 Genes found to be differentially expressed in PI fetal bone marrow appear 
in Table 14.  The most significant finding of this experiment was down-regulation 
of both c-fos and its transcriptional target in osteoclast precursor cells, Fosl1. Up-
regulation of the ISGs, ISG15 and RIG-I and CD14, which may also be 
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stimulated by interferon, were identified. CXCR4 was downregulated in PI bone 
marrow as well but the significance of this, if any, in context of decreased 
osteoclastogenesis in PI is uncertain as this factor has been shown to negatively 
regulated osteoclastogenesis (Hirbe et al., 2007). 
 
Table 14. Differential expression of genes associated with osteoclast 
differentiation in the bone marrow of day 192 PI.a 
Gene mRNA fold change 
versus control 
Gene functions 
c-fos -  2.6 Transcription factor activated by 
RANK/RANKL pathway 
Fosl1  -  2.0 Transcriptional Target of c-fos 
in osteoclast precursors 
CXCR4 -1.7 Chemotaxis and other immune 
functions as reviewed in 
(Smirnova et al., 2009) 
RIG-I + 11.7 Cytosolic RNA sensor (ISG) 
ISG15 + 152.9 Anti-viral activity 








 Down-regulation of the transcriptional target of c-fos, FosL1, suggests that 
either levels of diphosphorylated (activated) c-fos are decreased or Fosl1 
transcription is being depressed via another mechanism.  Western blot analysis 
of bone marrow protein extracts for diphosphorylated c-fos and Fosl1 are 
necessary to determine whether reduced levels of activated transcription factor 
are truly present and having an effect (decreased Fosl1 protein) on the protein 
level.  These experiment are currently underway.  However, regardless of the 
outcome of these planned experiments it will remain to be determined whether 
these changes are physiologically relevant.  A cause and effect relationship 
between decreases in c-fos and Fosl1 and impaired osteoclast differentiation, in 














FETAL SPLEEN AND BONE MARROW DNA METHYLATION 
 
Introduction 
 This series of experiments were undertaken in an attempt to gain 
understanding of two phenomena that occur following transplacental infections 
with BVDV.  As described in CHAPTER IV, PI fetuses appear to be unable to 
induce the expression IFN- or IFN- in response to PI but are able to respond to 
IFN as evidenced by a profound type I IFN response (ISG up regulation).  In 
contrast, cotyledons from PI fetuses appear to be able to induce both IFN- or 
IFN-.  BVDV as well as other pestiviruses, such as Classical Swine Fever Virus, 
have been shown to directly modulate the activity of interferon regulatory factors 
3 and 7 (Baigent et al., 2004; Baigent et al., 2002; Schweizer et al., 2006) and 
thus ablate type I IFN production, this mechanism is insufficient to explain the 
difference in type I IFN production as virus is present in similar amounts in both 
the cotyledons and fetal tissues. Thus it was hypothesized that type I IFN 
production may be silenced by epigenetic mechanisms in the fetus but not the 
placenta.  The second phenomenon that occurs following transplacental infection 
with BVDV is increased susceptibility to pathogens in postnatal life.  Increased 
susceptibility to pathogens is well documented in PI cattle but epidemiologic 
evidence suggests that a similar increase in susceptibility to pathogens occurs in 
fetuses transiently infected with BVDV during late gestation (Muñoz-Zanzi et al., 
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2004).  This suggests that the presence of the virus cannot completely account 
for immunosuppression and increased susceptibility to pathogens; rather 
transplacental infection during a critical period may result in developmental 
immune deficits.  Epigenetic mechanisms controlling gene expression include 
DNA methylation, DNA hydroxymethylation, histone deacetylation, and micro-
RNA.  It was hypothesized that transplacental infection results in epigenetic 
modification of the fetal genome and the epigenetic modification may result in 
silencing of genes essential for normal immune function.  
 
Materials and Methods 
Experiment I  - Global DNA methylation 
 Genomic DNA was extracted from days 82, 89, 97, 192, and 245 PI and 
Control fetuses day 190 PI, TI, and control fetal spleen using GeneElute, 
mammalian genomic miniprep kit (Sigma Aldrich, St. Louis, MO).  The latter day 
190 spleen samples were derived from a previous study(Smirnova et al., 2008) 
using the same viral strain with maternal inoculation on day 75 (PI) and day 175 
(TI). DNA was evaluated for quality and quantitated on a Nanodrop 
spectrophometer (Thermo Scientific, Wilmington, DE). Total genomic 5-
methylcytosine and 5-hydroxymethylcytosine content were determined by a 
commercial colorimetric ELISA, MethylFlash (Epigentek, Farmingdale, NY). 
Experiment II – Locus specific methylation 
 Genes downregulated (CXCR4, c-fos), within the bone marrow of day 192 
PI fetuses, which were identified in previous experiments in addition to genes 
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which were expected to be up regulated but were not  (IFN-, IFN-) were 
evaluated for the presence of cytosine paired to guanine (CpG) islands within 
their promotors regions. Promotor sequences were identified using Ensembl 
Genome Browser (www.ensembl.org) and a 3000 base pair region upstream 
from the start codon was evaluated for the presence of CpG islands by using the 
criteria previously described (Wang and Leung, 2004).  Genes found to contain 
CpG islands within their promotors and meeting the published criteria were 
evaluated by Methylation Sensitive Endonuclease Restriction–PCR (MSRE-PCR) 
to determine the extent of 5-methycytosine modifications at specific loci.  Primers 
were designed to amplify a region containing no less than three restriction sites.  
Primer sequences appear in Table 15.  MSRE-PCR was performed with 
OneStep qMethyl kit (Zymo Research, Irvine, CA).  This kit contains a mixture of 
MSREs and is a real-time PCR assay.  The assay is performed by comparing the 
differences in amplification (delta Ct) between two reactions; a reference reaction 
which does not containing MSREs and a test reaction that contains MSREs.  If 
the locus of interested is unmethylated, digestion occurs, little product is 
amplified in the PCR reaction.  In contrast, if the locus is methylated there is 
robust amplification of the product. 
 
Results 
 Experiment I 
 The results appear in Figures 18,19 and 20. There was no difference in 
DNA hydroxymethylation content between PI and Control fetuses at days 97, 192 
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and 245 of gestation (data not shown). 
 
Table 15. Primer sequences for MSRE-PCR 
Target Gene Ensembl number Primer sequence 
c-fos ENSBTAG00000004322  F: CAGGGACCTGTGTCTCTGC 
R: CCTAGCCTCCTGCTCAGATG 




















Figure 18.  Global DNA 5-methylcytosine and 5-hydroxymethylcytosine content from 
spleen of Day 190 PI, TI (transiently infected), and Control fetuses.  (A) Global DNA 
methylation is increased in PI fetuses (P < 0.05) and tends to be increased in TI fetuses 




fetuses (P < 0.05.) 
 
 
Figure 19. Global DNA methylation in PI and Control fetal spleens from days 89, 97, 
192, and 245 of gestation.  There is a greater concentration of 5-methylcytosine in PI 










Figure 20. Global DNA methylation of fetal bone marrow from day 192 of gestation. 
There is no difference between 5-methylcytosine concentration in PI and Control 
fetuses.   
  
Experiment II 
 The results of locus specific DNA methylation analysis are presented in 
Table 16.  There were no differences between PI and Control fetuses on Day 190 
in the percent of DNA methylation within the CXCR4 and c-fos promotors.  
CXCR4 appears to be hypomethylated when compared to c-fos, suggesting that 
transcription of the latter gene may be silenced in a majority of bone marrow cells 
by this mechanism.   
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Table 16. Percent methylation of CXCR4 and c-fos in bone marrow of day 192 PI 
and Control fetuses. 
Infection status Percent methylation at locus 
CXCR4 c-fos 
Control 2.8  2.6 86.7  16.7 




 In experiment I, PI fetuses on day 190 had global hypermethylation of 
spleen DNA, which may be associated with either silencing of genes or 
differences in populations of cells that have different degrees of methylation. 
Interestingly, TI fetal spleen DNA tended to have a similar degree of global 
hypermethylation and hyperhydroxymethylation as PI fetal spleen DNA, however, 
because these fetuses were in the acute stage of BVDV infection, it is difficult to 
interpret the significance of these findings. It is uncertain why day 192 PI fetuses 
in current experiment did not mirror the hypermethylation of DNA present in the 
day 190 PI fetuses from the previous experiment. Rather, hypermethylation of 
global spleen DNA was not observed in the current experiment until day 245.    
One potential reason as stated previously in APPENDIX I is that fetuses from the 
current experiment were less severely affected than those from the previous 
experiment. Cell lineage specific assessment of DNA methylation would be 
required to determine the significance, if any, of these findings.  Although c-fos 
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transcription appears to be regulated by DNA methylation, no effect of PI was 
observed on the degree of methylation suggesting that downregulation of this 






















LIST OF ABBREVIATIONS 
 
BVDV - bovine viral diarrhea virus;  
cp -cytopathic;  
dpmi – days post maternal infection;  
dsRNA – double-stranded RNA;  
IFN - interferon;  
IFN-I – type one interferon; 
ISG - interferon stimulated gene; 
RIGI – retinoic acid inducible gene 1; 
MDA5 - melanoma differentiation-associated protein 5;  
ncp - noncytopathic;  
PAMP – pathogen associated molecular pattern; 
PI – persistently infected; 
qRT-PCR - Semi-quantitative real time polymerase chain reaction 
 
 
 
 
 
 
